Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Neonatology

  Free Subscription


Articles published in Pediatr Pulmonol

Retrieve available abstracts of 573 articles:
HTML format



Single Articles


    May 2024
  1. DOSSCHE L, Kersten C, van Rosmalen J, Wijnen R, et al
    Lower respiratory tract infections in children with congenital lung abnormalities.
    Pediatr Pulmonol. 2024 May 21. doi: 10.1002/ppul.27067.
    PubMed     Abstract available


  2. CHEN C, Jin Y, Jin H, Chen S, et al
    Adipose mesenchymal stem cells-derived exosomes attenuated hyperoxia-induced lung injury in neonatal rats via inhibiting the NF-kappaB signaling pathway.
    Pediatr Pulmonol. 2024 May 21. doi: 10.1002/ppul.27057.
    PubMed     Abstract available


  3. NOBILE S, Catalano P, Perri A, Lio A, et al
    Lung agenesis in a preterm infant: Lung function test findings in the first 2 years of life.
    Pediatr Pulmonol. 2024 May 15. doi: 10.1002/ppul.27042.
    PubMed    


  4. MANIACI J, Kearney MD, DeMauro SB, Panitch H, et al
    Lived experiences of caregivers with infants treated at home with continuous invasive or noninvasive ventilation.
    Pediatr Pulmonol. 2024 May 15. doi: 10.1002/ppul.27063.
    PubMed     Abstract available


  5. RAO T, Zhou Y, Chen C, Chen J, et al
    Recent progress in neonatal hyperoxic lung injury.
    Pediatr Pulmonol. 2024 May 14. doi: 10.1002/ppul.27062.
    PubMed     Abstract available


  6. SANCHEZ-FERRER F, Nso-Roca AP
    Unusually severe neonatal presentation of mediastinal bronchogenic cyst.
    Pediatr Pulmonol. 2024 May 14. doi: 10.1002/ppul.27048.
    PubMed     Abstract available


  7. DE MEDEIROS CAVALCANTE MENEGHE, Aragon DC, Calixto C, Ferreira CHF, et al
    Personalized lung care: Bronchopulmonary dysplasia risk prediction tool tailored for neonates born in resource-limited settings.
    Pediatr Pulmonol. 2024 May 7. doi: 10.1002/ppul.27049.
    PubMed     Abstract available


  8. BULLON-GONZALEZ I, Cabeza-Arce N, Andres-Porras P, Ferrer-Ortiz I, et al
    Lessons from Covid: Effect of community mask use on infant hospitalizations for respiratory infections.
    Pediatr Pulmonol. 2024 May 7. doi: 10.1002/ppul.27043.
    PubMed    


  9. WU YH, Hsiao CH, Chen YL, Tsai LY, et al
    Rare type of tracheal agenesis: Unexpected presentation and immediate consideration of emergent esophageal intubation in neonatal resuscitation program. Case reports and review of the literature.
    Pediatr Pulmonol. 2024 May 2. doi: 10.1002/ppul.26990.
    PubMed     Abstract available


  10. KAY DM, Sadeghi H, Kier C, Berdella M, et al
    Genetic counseling access and service delivery in New York State is variable for parents of infants with complex CFTR genotypes conferring uncertain phenotypes.
    Pediatr Pulmonol. 2024 May 2. doi: 10.1002/ppul.27023.
    PubMed     Abstract available


  11. JIMENEZ-NOGUEIRA E, Bueno-Rebollo C, Garcia-Jerez B, Callejon-Fernandez E, et al
    Impact of breastfeeding on ICU admissions and need for mechanical ventilation in infants younger than 6 months with RSV+ bronchiolitis. An observational study.
    Pediatr Pulmonol. 2024 May 2. doi: 10.1002/ppul.27036.
    PubMed     Abstract available


  12. URQUHART DS, Dowle H, Moffat K, Forster J, et al
    Lung clearance index (LCI(2.5)) changes after initiation of Elexacaftor/Tezacaftor/Ivacaftor in children with cystic fibrosis aged between 6 and 11 years: The "real-world" differs from trial data.
    Pediatr Pulmonol. 2024;59:1449-1453.
    PubMed     Abstract available


  13. YOUSIF D, Cerini C, Ward S, Iyer N, et al
    Retrospective study of serial polysomnograms of bronchopulmonary dysplasia patients with oxygen dependence.
    Pediatr Pulmonol. 2024;59:1418-1427.
    PubMed     Abstract available


  14. BENDOUKHA I, Boucherit-Otmani Z, Baba Ahmed-Kazi Tani ZZ, Seghir A, et al
    Initial characteristics of cystic fibrosis in Algeria: Description of 34 pediatric cases.
    Pediatr Pulmonol. 2024;59:1454-1461.
    PubMed     Abstract available


  15. HARRIGAN M, Jessup M, Bennett K, Mulrennan S, et al
    Me, myself, and I: A systematic review of cystic fibrosis and self-concept.
    Pediatr Pulmonol. 2024;59:1175-1195.
    PubMed     Abstract available


  16. GAMBAZZA S, Mariani A, Guarise R, Ferrari B, et al
    Short-term effects of positive expiratory pressure mask on ventilation inhomogeneity in children with cystic fibrosis: A randomized, sham-controlled crossover study.
    Pediatr Pulmonol. 2024;59:1354-1363.
    PubMed     Abstract available


  17. WRIGHT BA, De Andrade LM, Dumitrescu AV, Larson SA, et al
    A new vision: Integration of ophthalmology services into an interdisciplinary pediatric cystic fibrosis clinic model.
    Pediatr Pulmonol. 2024;59:1502-1504.
    PubMed    


  18. ATTEIH SE, Armbruster CR, Hilliam Y, Rapsinski GJ, et al
    Effects of highly effective modulator therapy on the dynamics of the respiratory mucosal environment and inflammatory response in cystic fibrosis.
    Pediatr Pulmonol. 2024;59:1266-1273.
    PubMed     Abstract available


  19. POULSEN M, Holland AE, Button B, Jones AW, et al
    Preferences and perspectives regarding telehealth exercise interventions for adults with cystic fibrosis: A qualitative study.
    Pediatr Pulmonol. 2024;59:1217-1226.
    PubMed     Abstract available


    April 2024
  20. ARADHYA AS, Ghalige SS, Madarkar B, Pruthvishree HV, et al
    Comparison of porcine versus bovine surfactant in preterm respiratory distress syndrome: Evidence from real-world data. A multicentre collaboration from Karnataka.
    Pediatr Pulmonol. 2024 Apr 25. doi: 10.1002/ppul.27032.
    PubMed     Abstract available


  21. TSOU PY, Tapia IE
    Tracheostomy and inpatient outcomes among children with congenital central hypoventilation syndrome: A kids' inpatient database study.
    Pediatr Pulmonol. 2024 Apr 17. doi: 10.1002/ppul.27015.
    PubMed     Abstract available


  22. LOHMANN P, Hagan JL, Fernandes CJ
    A breath of fresh air: Does spontaneous breathing and early repair in neonates with very mild congenital diaphragmatic hernia lead to earlier discharge?
    Pediatr Pulmonol. 2024 Apr 17. doi: 10.1002/ppul.27003.
    PubMed    


  23. LEFEVERE J, van Delft B, Decaluwe W, Derriks F, et al
    Neurally adjusted ventilatory assist in preterm infants: A systematic review and meta-analysis.
    Pediatr Pulmonol. 2024 Apr 3. doi: 10.1002/ppul.27001.
    PubMed     Abstract available


  24. DUDOIGNON B, Khirani S, Vedrenne-Cloquet M, Amaddeo A, et al
    Work of breathing: A tool for the respiratory management of severe bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2024;59:1128-1132.
    PubMed    


  25. TAMER G, Arets HGM, van der Ent CK, van Santen HM, et al
    BMI increase during early childhood in boys with cystic fibrosis and early adrenarche.
    Pediatr Pulmonol. 2024;59:991-996.
    PubMed     Abstract available


  26. VAZIRI S, McGarry ME, Huang CY, Cuneo AA, et al
    Time to be blunt: Substance use in cystic fibrosis.
    Pediatr Pulmonol. 2024;59:1015-1027.
    PubMed     Abstract available


  27. WELSNER M, Gruber W, Blosch C, Olivier M, et al
    Impact of habitual physical activity and exercise capacity on quality of life in adolescents and adults with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:949-963.
    PubMed     Abstract available


  28. ZAFAR A, Hall M
    Types of home respiratory support in children with bronchopulmonary dysplasia and factors determining its duration: A scoping review.
    Pediatr Pulmonol. 2024;59:834-844.
    PubMed     Abstract available


  29. POWER HA, Shivak SM, Kim J, Wright KD, et al
    A systematic review of attention-deficit/hyperactivity disorder in people living with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:825-833.
    PubMed     Abstract available


  30. ZWITSERLOOT AM, Verhoog FA, van den Berge M, Gappa M, et al
    Comparison of particles in exhaled air and multiple breath washout for assessment of small airway function in children with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:915-922.
    PubMed     Abstract available


  31. PATEL N, Ansar M, Pham A, Thomsen K, et al
    Gilbert's syndrome leads to elevated bilirubin after initiation of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:863-866.
    PubMed     Abstract available


  32. MAYNARD R, Armstrong M, O'Grady K, Moore B, et al
    Predischarge death or lung transplantation in tracheostomy and ventilator dependent grade 3 bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2024;59:867-873.
    PubMed     Abstract available


  33. SUBRAMANIAN P, Singhal M, Sharma A
    Unique segmental branching of right pulmonary artery in association with patent ductus arteriosus and anomalous carotid origin of left vertebral artery.
    Pediatr Pulmonol. 2024;59:1092-1094.
    PubMed    


    March 2024
  34. LEON-ASTUDILLO C, Dy FJ, McCown MY, Perez IA, et al
    ATS core curriculum 2023. Pediatric pulmonary medicine: Respiratory disorders in infants.
    Pediatr Pulmonol. 2024 Mar 28. doi: 10.1002/ppul.26961.
    PubMed     Abstract available


  35. MIZOGAMI M, Hasegawa H, Yamada Y, Wasa M, et al
    Examination of changes in the breathing intolerance index to determine the respiratory support needs of very low birth weight infants.
    Pediatr Pulmonol. 2024 Mar 19. doi: 10.1002/ppul.26969.
    PubMed     Abstract available


  36. DE QUEIROZ ANDRADE E, Sena CRDS, de Gouveia Belinelo P, Robinson PD, et al
    In utero smoking exposure induces changes to lung clearance index and modifies risk of wheeze in infants.
    Pediatr Pulmonol. 2024 Mar 19. doi: 10.1002/ppul.26975.
    PubMed     Abstract available


  37. TARRELL A, Grinsell M, Lewis KW, Yoder BA, et al
    Bronchopulmonary dysplasia severity and bone status in preterm infants.
    Pediatr Pulmonol. 2024 Mar 19. doi: 10.1002/ppul.26967.
    PubMed    


  38. NOUR BA, El-Rahman AMA, Hameed SAEAE, Mohsen N, et al
    Lung and diaphragm ultrasound as predictors of successful weaning from nasal continuous positive airway pressure in preterm infants.
    Pediatr Pulmonol. 2024 Mar 19. doi: 10.1002/ppul.26933.
    PubMed     Abstract available


  39. PERRI A, Prontera G, Fattore S, Sbordone A, et al
    Tracheal bronchus related symptoms in a premature neonate: The role of lung ultrasound in the management of this condition.
    Pediatr Pulmonol. 2024 Mar 5. doi: 10.1002/ppul.26944.
    PubMed    


  40. DANI C, Miselli F, Zini T, Scarponi D, et al
    Measurement of lung oxygenation by near-infrared spectroscopy in preterm infants with bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2024 Mar 5. doi: 10.1002/ppul.26955.
    PubMed     Abstract available


  41. MUEHLBACHER T, Boos V, Geiger LB, Ruegger CM, et al
    Analgosedation for less-invasive surfactant administration: Variations in practice.
    Pediatr Pulmonol. 2024;59:750-757.
    PubMed     Abstract available


  42. ALIYEV F, Kayki G, Annakkaya Kocyigit T, Iyigun I, et al
    Lung ultrasound scores within the first 3 days of life to predict respiratory outcomes.
    Pediatr Pulmonol. 2024;59:662-668.
    PubMed     Abstract available


  43. DRESS C, Hente E, Hossain MM, Hardie W, et al
    Body composition in children with cystic fibrosis treated with CFTR modulators versus modulator naive individuals.
    Pediatr Pulmonol. 2024;59:805-808.
    PubMed    


  44. JAMES A, Li G, List R, Lonabaugh K, et al
    Analysis of iron status after initiation of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:669-678.
    PubMed     Abstract available


  45. MOLITOR SJ, Fidler AL, Sinisterra M, Everhart RS, et al
    Associations between symptoms of ADHD/ODD and health outcomes in youth with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:809-812.
    PubMed    


  46. GRUBE PM, Autry EB, Kormelink LN, Young DC, et al
    A decade of change: The evolution of pharmacy services at U.S. cystic fibrosis centers.
    Pediatr Pulmonol. 2024;59:652-661.
    PubMed     Abstract available


  47. WOZNIAK PS, Makhoul L, Botros MM
    Bronchopulmonary dysplasia in adults: Exploring pathogenesis and phenotype.
    Pediatr Pulmonol. 2024;59:540-551.
    PubMed     Abstract available


  48. ABBINANTI A, Witt DM, Saunders J, Jones AE, et al
    Venous thromboembolism management in people with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:584-591.
    PubMed     Abstract available


  49. BOUTELEUX B, Beaufils F, Fayon M, Bui S, et al
    Home-spirometry exacerbation profiles in children with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:552-561.
    PubMed     Abstract available


  50. MANTI S, Giallongo A, Parisi GF, Papale M, et al
    Combining biologics and CFTR modulators is safe: A pilot, observational, monocenter study.
    Pediatr Pulmonol. 2024;59:801-804.
    PubMed    


  51. CURATOLA A, Corona F, Squillaci D, Saccari A, et al
    Lung ultrasound evaluation in people with cystic fibrosis: A new approach in the pulmonology outpatient clinic.
    Pediatr Pulmonol. 2024;59:592-599.
    PubMed     Abstract available


  52. KIER C, Kay DM, Langfelder-Schwind E, Goetz DM, et al
    Variability in evaluation and follow-up of newborns with CRMS/CFSPID in New York State.
    Pediatr Pulmonol. 2024 Mar 1. doi: 10.1002/ppul.26928.
    PubMed    


    February 2024
  53. BHATIA H, Bhatia A, Mathew JL, Saxena AK, et al
    Tracheobronchial abnormalities on computed tomography angiography in children with congenital heart disease.
    Pediatr Pulmonol. 2024 Feb 20. doi: 10.1002/ppul.26934.
    PubMed     Abstract available


  54. LEON-ASTUDILLO C, Brooks O, Salabarria SM, Coker M, et al
    Longitudinal changes of swallowing safety and efficiency in infants with spinal muscular atrophy who received disease modifying therapies.
    Pediatr Pulmonol. 2024 Feb 15. doi: 10.1002/ppul.26919.
    PubMed     Abstract available


  55. BUENDIA JA, Acuna-Cordero R, Rodriguez-Martinez CE
    Exploratory analysis of the economically justifiable price of nirsevimab for healthy late-preterm and term infants in Colombia.
    Pediatr Pulmonol. 2024 Feb 15. doi: 10.1002/ppul.26920.
    PubMed     Abstract available


  56. LAHIRI T, VanNostrand J, Faricy L, Twichell S, et al
    Profound electrolyte and acid-base disturbances in an infant with cystic fibrosis.
    Pediatr Pulmonol. 2024 Feb 15. doi: 10.1002/ppul.26924.
    PubMed    


  57. NOBILE S, Sbordone A, Salce N, Patti ML, et al
    Diaphragm atrophy during invasive mechanical ventilation is related to extubation failure in preterm infants: An ultrasound study.
    Pediatr Pulmonol. 2024 Feb 14. doi: 10.1002/ppul.26818.
    PubMed     Abstract available


  58. DASSIOS T, Vervenioti A, Tsintoni A, Fouzas S, et al
    Flow-resistive loading and diaphragmatic muscle function in term and preterm infants.
    Pediatr Pulmonol. 2024 Feb 14. doi: 10.1002/ppul.26899.
    PubMed     Abstract available


  59. EL-FARAMAWY A, Nasr SZ, Emam MMSA, Fahmy HMH, et al
    Clinical and genetic risk factors for cystic fibrosis-related liver disease in Egyptian CF children: A single-center experience.
    Pediatr Pulmonol. 2024;59:465-471.
    PubMed     Abstract available


  60. PLATT T, Kormelink LN, Autry EB, Rossoll SJ, et al
    Assessment of long-term medication adherence with cystic fibrosis: An integrated approach.
    Pediatr Pulmonol. 2024;59:458-464.
    PubMed     Abstract available


  61. WRIGHT BA, Knockel LM
    Unlocking the power of pharmacy services and accelerating access to medications: An update to the impact of pharmacy services on cystic fibrosis transmembrane conductance regulator modulator prescribing at a pediatric cystic fibrosis center.
    Pediatr Pulmonol. 2024;59:526-527.
    PubMed    


  62. TIWARI SK, Sharma R, Joshi P, Lodha R, et al
    Knowledge, attitude, and practices among caregivers of children with Cystic Fibrosis.
    Pediatr Pulmonol. 2024;59:449-457.
    PubMed     Abstract available


  63. STEUART R, Pan AY, Woolums A, Benscoter D, et al
    Respiratory culture growth and 3-years lung health outcomes in children with bronchopulmonary dysplasia and tracheostomies.
    Pediatr Pulmonol. 2024;59:300-313.
    PubMed     Abstract available


  64. COLLACO JM, Tsukahara KR, Tracy MC, Sheils CA, et al
    Number of children in the household influences respiratory morbidities in children with bronchopulmonary dysplasia in the outpatient setting.
    Pediatr Pulmonol. 2024;59:314-322.
    PubMed     Abstract available


    January 2024
  65. DIRICKX M, Vermeulen F, Boon M, Debeer A, et al
    Multiple breath washout measurements in school aged patients with congenital diaphragmatic hernia.
    Pediatr Pulmonol. 2024 Jan 30. doi: 10.1002/ppul.26888.
    PubMed    


  66. ZIREK F, Ozcan G, Tekin MN, Ucar CI, et al
    An infant with episodic stridor and respiratory crises since birth: A challenging diagnosis.
    Pediatr Pulmonol. 2024 Jan 22. doi: 10.1002/ppul.26866.
    PubMed    


  67. DANI C, Napolitano M, Barone C, Manna A, et al
    Nasal intermittent positive pressure ventilation during less invasive surfactant administration in preterm infants: An open-label randomized controlled study.
    Pediatr Pulmonol. 2024 Jan 22. doi: 10.1002/ppul.26879.
    PubMed     Abstract available


  68. AMITAI N, Stafler P, Blau H, Kaplan E, et al
    Cardiopulmonary exercise testing in adolescence following extremely premature birth.
    Pediatr Pulmonol. 2024 Jan 19. doi: 10.1002/ppul.26867.
    PubMed     Abstract available


  69. KOUCKY V, Martinu V, Koucky M
    Impaired lung function in infants with primary ciliary dyskinesia: A pilot Czech study.
    Pediatr Pulmonol. 2024 Jan 11. doi: 10.1002/ppul.26863.
    PubMed    


  70. KIMURA S, Toyoshima K, Shimokaze T, Katsumata K, et al
    Respiratory function testing for guiding ventilator mode conversion in congenital diaphragmatic hernia.
    Pediatr Pulmonol. 2024 Jan 11. doi: 10.1002/ppul.26789.
    PubMed     Abstract available


  71. MILESI C, Nogue E, Baleine J, Moulis L, et al
    ROX (Respiratory rate-OXygenation) index to predict early response to high-flow nasal cannula therapy in infants with viral bronchiolitis.
    Pediatr Pulmonol. 2024 Jan 10. doi: 10.1002/ppul.26860.
    PubMed     Abstract available


  72. MADANI KIA T, McKinney M, Dicken B, Thompson A, et al
    Clinical curiosity: How long should we wait? Management of ventilator associated pneumatocele in an extremely preterm infant.
    Pediatr Pulmonol. 2024 Jan 9. doi: 10.1002/ppul.26834.
    PubMed    


  73. YASA B, Kersin SG, Cetinkaya M, Ozek E, et al
    Regional pulmonary oxygen saturations in late preterm and term infants with respiratory distress at birth.
    Pediatr Pulmonol. 2024 Jan 5. doi: 10.1002/ppul.26849.
    PubMed     Abstract available


  74. LEVY Y, Bitton L, Sileo C, Rambaud J, et al
    Lung biopsies in infants and children in critical care situation.
    Pediatr Pulmonol. 2024 Jan 2. doi: 10.1002/ppul.26845.
    PubMed     Abstract available


  75. SHAH K, Schindler T, Myers RE, Sankararaman S, et al
    Pancreatic cystosis in cystic fibrosis.
    Pediatr Pulmonol. 2024;59:210-212.
    PubMed    


  76. LEE J, Husami A, Arora K, Zhang W, et al
    A personalized medicine approach to optimize care for a pediatric cystic fibrosis patient with atypical clinical symptoms.
    Pediatr Pulmonol. 2024;59:229-232.
    PubMed    


  77. HANGER S, Felton I, Ukor EF, Bowman E, et al
    The effectiveness of CFTR modulators in people with CF and rare mutations: A real-world study.
    Pediatr Pulmonol. 2024;59:221-224.
    PubMed    


  78. HJELM M, Hente E, Schuler CL, Duan Q, et al
    Education-related needs for children with cystic fibrosis: Perspectives of US pediatric care teams.
    Pediatr Pulmonol. 2024;59:95-100.
    PubMed     Abstract available


  79. LINDLEY B, Bhakta Z, Leclair L, Young DC, et al
    The pharmacokinetics and pharmacodynamics of continuous infusion vancomycin in adult people with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:89-94.
    PubMed     Abstract available


  80. KOW S, Rieger B, Morse K, Keens T, et al
    The positive impact of journaling on adolescents with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:63-71.
    PubMed     Abstract available


    December 2023
  81. GAYOSO-LIVIAC MG, Nino G, Montgomery AS, Hong X, et al
    Infants hospitalized with lower respiratory tract infections during the first two years of life have increased risk of pediatric obstructive sleep apnea.
    Pediatr Pulmonol. 2023 Dec 28. doi: 10.1002/ppul.26810.
    PubMed     Abstract available


  82. CORCORAN A, Faig W, Ren CL
    Clinical features associated with pulmonary exacerbation diagnosis in infants and young children with cystic fibrosis.
    Pediatr Pulmonol. 2023 Dec 22. doi: 10.1002/ppul.26838.
    PubMed     Abstract available


  83. KATO M, Mochizuki H, Kama Y, Kusuda S, et al
    Palivizumab prophylaxis in preterm infants and subsequent wheezing/asthma: 10-year follow-up study.
    Pediatr Pulmonol. 2023 Dec 20. doi: 10.1002/ppul.26824.
    PubMed     Abstract available


  84. STOFFELLA S, Ly N, McGarry M, Neemuchwala F, et al
    Cystic fibrosis transmembrane conductance regulator modulator administration to a F508del heterozygous infant with meconium pseudocyst and short bowel syndrome: A case report.
    Pediatr Pulmonol. 2023 Dec 13. doi: 10.1002/ppul.26809.
    PubMed    


  85. SENA CRDS, Morten M, Collison AM, Shaar A, et al
    Bronchiolitis hospital admission in infancy is associated with later preschool ventilation inhomogeneity.
    Pediatr Pulmonol. 2023 Dec 13. doi: 10.1002/ppul.26793.
    PubMed     Abstract available


  86. ELIJAH J, Fitzgerald LJ, Phan H
    Use of CFTR modulators in special populations, part 1: Pregnancy and lactation.
    Pediatr Pulmonol. 2023;58:3377-3385.
    PubMed     Abstract available


  87. ELIJAH J, Fitzgerald LJ, Phan H
    Use of CFTR modulators in special populations, part 2: Severe lung disease.
    Pediatr Pulmonol. 2023;58:3386-3392.
    PubMed     Abstract available


  88. TEPER A, Lubovich S, Rodriguez V, Zaragoza S, et al
    Real-life experience with a generic formulation of lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for the Phe508del CFTR mutation.
    Pediatr Pulmonol. 2023;58:3560-3565.
    PubMed     Abstract available


  89. LEBECQUE P, Thimmesch M, Meurrens J, Jeanmart P, et al
    Cystic fibrosis: Does it matter to avoid crushing Elexacaftor/Tezacaftor/Ivacaftor (ETI) tablets?
    Pediatr Pulmonol. 2023;58:3603-3604.
    PubMed    


  90. ZHANG R, Sun Y
    A Chinese pediatric cystic fibrosis patient with the c.1624G>T, p. Gly542x/c.223C>T, p. Arg75x genotype.
    Pediatr Pulmonol. 2023;58:3619-3621.
    PubMed    


  91. ANDERTON KA, Christensen R, Zobell JT
    Impact of pharmacy services on people with cystic fibrosis (PwCF) immunization rates.
    Pediatr Pulmonol. 2023;58:3622-3625.
    PubMed    


  92. MANCIULLI T, Bresci S, Mencarini J, Avarello A, et al
    Prevalence of adverse events in cystic fibrosis patients treated with elexacaftor/tezacaftor/ivacaftor: Experience of the regional referral center in Tuscany, Italy.
    Pediatr Pulmonol. 2023;58:3626-3629.
    PubMed    


  93. BLANCO-ORIVE P, Del Corral T, Martin-Casas P, Cebria I Iranzo MA, et al
    Spanish adaptation and validation of the child- and parent-report cystic fibrosis questionnaire-revised (CFQ-R).
    Pediatr Pulmonol. 2023;58:3447-3457.
    PubMed     Abstract available


  94. KADOUH NK, Elijah J, Fitzgerald LJ, Phan H, et al
    Use of CFTR modulators in special populations, part 3: Solid organ transplant.
    Pediatr Pulmonol. 2023;58:3393-3402.
    PubMed     Abstract available


  95. DUNCAN DR, Golden C, Larson K, Williams N, et al
    Breastfeeding in infants who aspirate may increase risk of pulmonary inflammation.
    Pediatr Pulmonol. 2023 Dec 1. doi: 10.1002/ppul.26788.
    PubMed     Abstract available


  96. LIPTZIN DR, McGraw MD, Stidham T, Wambach JA, et al
    Noninvasive management of infants with SFTPC pathogenic variants.
    Pediatr Pulmonol. 2023 Dec 1. doi: 10.1002/ppul.26722.
    PubMed    


    November 2023
  97. KIPFMUELLER F, Leyens J, Pugnaloni F, Bo B, et al
    Spontaneous breathing in selected neonates with very mild congenital diaphragmatic hernia.
    Pediatr Pulmonol. 2023 Nov 29. doi: 10.1002/ppul.26791.
    PubMed     Abstract available


  98. GUSTAFSON B, Pinto S
    A unique case of pneumocystis pneumonia in infancy.
    Pediatr Pulmonol. 2023 Nov 28. doi: 10.1002/ppul.26776.
    PubMed    


  99. SCHROEDER L, Pommer K, Geipel A, Strizek B, et al
    A comparative analysis of the Vasoactive-Inotropic Score, the Vasoactive-Ventilation-Renal Score, and the Oxygenation Index as outcome predictors in infants with a congenital diaphragmatic hernia.
    Pediatr Pulmonol. 2023 Nov 28. doi: 10.1002/ppul.26785.
    PubMed     Abstract available


  100. ZHU Z, He Y, Yuan L, Chen L, et al
    Trends in bronchopulmonary dysplasia and respiratory support among extremely preterm infants in China over a decade.
    Pediatr Pulmonol. 2023 Nov 28. doi: 10.1002/ppul.26761.
    PubMed     Abstract available


  101. OESTREICH MA, Hanni R, Wyler F, Kentgens AC, et al
    Comparison of functional residual capacity between updated infant SF(6) multiple-breath washout setups.
    Pediatr Pulmonol. 2023 Nov 27. doi: 10.1002/ppul.26770.
    PubMed    


  102. JANUSKA MN, Langfelder-Schwind E, Vicencio AG, Berdella MN, et al
    Persistent lobar atelectasis in an infant with cystic fibrosis: The role for flexible bronchoscopy and poractant alfa.
    Pediatr Pulmonol. 2023 Nov 17. doi: 10.1002/ppul.26757.
    PubMed    


  103. WENDEL K, Rossholt ME, Gunnarsdottir G, Aas MF, et al
    Lung function in preterm infants at 3 months corrected age after neonatal LC-PUFA supplementation.
    Pediatr Pulmonol. 2023 Nov 17. doi: 10.1002/ppul.26760.
    PubMed     Abstract available


  104. TSOI SM, Nawaytou H, Almeneisi H, Steurer M, et al
    Prostaglandin-E1 infusion in persistent pulmonary hypertension of the newborn.
    Pediatr Pulmonol. 2023 Nov 17. doi: 10.1002/ppul.26759.
    PubMed     Abstract available


  105. THOMANN J, Gaertner VD, Waldmann AD, Plastina L, et al
    Nasal high frequency oscillatory highflow therapy in preterm infants: A randomized crossover trial.
    Pediatr Pulmonol. 2023 Nov 8. doi: 10.1002/ppul.26748.
    PubMed     Abstract available


  106. GUSTAFSON B, Britt RD Jr, Eisner M, Narayanan D, et al
    Predictors of recurrent wheezing in late preterm infants.
    Pediatr Pulmonol. 2023 Nov 3. doi: 10.1002/ppul.26739.
    PubMed     Abstract available


  107. DONADIO MVF, Barbosa MA, Vendrusculo FM, Ramirez TI, et al
    Mechanisms of ventilatory limitation to maximum exercise in children and adolescents with chronic airway diseases.
    Pediatr Pulmonol. 2023;58:3293-3302.
    PubMed     Abstract available


  108. GUR M, Manor E, Hanna M, Simaan N, et al
    The effect of inspiratory muscle training in PCD and CF patients: A pilot study.
    Pediatr Pulmonol. 2023;58:3264-3270.
    PubMed     Abstract available


  109. KIM J, Lyman B, Savant AP
    Cystic fibrosis year in review 2022.
    Pediatr Pulmonol. 2023;58:3013-3022.
    PubMed     Abstract available


  110. MONDEJAR-LOPEZ P, Moreno-Galarraga L, de Manuel-Gomez C, Blitz-Castro E, et al
    SARS-CoV-2 infection in children with cystic fibrosis: A cross-sectional multicenter study in Spain. New waves, new knowledge.
    Pediatr Pulmonol. 2023;58:3195-3205.
    PubMed     Abstract available


  111. STRATI MF, Bassi M, Pescini R, Ciprandi R, et al
    Mixed educational camps for children and adolescents with type 1 diabetes and cystic fibrosis: A new therapeutic alliance.
    Pediatr Pulmonol. 2023;58:3346-3348.
    PubMed    


  112. FOUZAS S, Kogias C, Gioulvanidou M, Bertzouanis A, et al
    Low-frequency oscillometry indices to assess ventilation inhomogeneity in CF patients.
    Pediatr Pulmonol. 2023;58:3147-3155.
    PubMed     Abstract available


  113. MOHAN M, Mannil A, Chandrasekaran V, Gulati R, et al
    Normative data for aquagenic wrinkling of palms in children 1-15 years of age: A cross-sectional study.
    Pediatr Pulmonol. 2023;58:3133-3138.
    PubMed     Abstract available


  114. HUANG L, Lai HJ, Song J, Zhao Z, et al
    Impact of intrinsic and extrinsic risk factors on early-onset lung disease in cystic fibrosis.
    Pediatr Pulmonol. 2023;58:3071-3082.
    PubMed     Abstract available


    October 2023
  115. BALDWIN K, Barker EM, Carayannopoulos M, Farrell PM, et al
    Severe lung disease in children with cystic fibrosis missed in newborn screening.
    Pediatr Pulmonol. 2023 Oct 27. doi: 10.1002/ppul.26734.
    PubMed     Abstract available


  116. GOUSSARD P, van Wyk L, Venkatakrishna S, Andronikou S, et al
    Removal of bronchial foreign body in a ventilated preterm infant with flexible bronchoscopy.
    Pediatr Pulmonol. 2023 Oct 20. doi: 10.1002/ppul.26731.
    PubMed    


  117. SCHOLTEN AWJ, Zhan Z, Niemarkt HJ, Vervoorn M, et al
    Cardiorespiratory monitoring with a wireless and nonadhesive belt measuring diaphragm activity in preterm and term infants: A multicenter non-inferiority study.
    Pediatr Pulmonol. 2023 Oct 5. doi: 10.1002/ppul.26695.
    PubMed     Abstract available


  118. GILTMIER AJ, Higano NS, Woods JC, Kingma PS, et al
    Evaluation of regional lung mass and growth in neonates with bronchopulmonary dysplasia using ultrashort echo time magnetic resonance imaging.
    Pediatr Pulmonol. 2023 Oct 3. doi: 10.1002/ppul.26705.
    PubMed     Abstract available


  119. EDMONDSON C, Westrupp N, Short C, Seddon P, et al
    Unsupervised home spirometry is not equivalent to supervised clinic spirometry in children and young people with cystic fibrosis: Results from the CLIMB-CF study.
    Pediatr Pulmonol. 2023;58:2871-2880.
    PubMed     Abstract available


  120. XU C, Tang Y, Dong L, Shen Y, et al
    Clinical and genetic characteristics of children with cystic fibrosis in Henan China: A single-center retrospective analysis.
    Pediatr Pulmonol. 2023;58:2865-2870.
    PubMed     Abstract available


  121. CONLON S, Glenn T
    Less invasive surfactant administration: Fine tuning a disparate practice.
    Pediatr Pulmonol. 2023;58:2701-2702.
    PubMed    


  122. GATT D, Shaw M, Waters V, Kritzinger F, et al
    Treatment response to pulmonary exacerbation in primary ciliary dyskinesia.
    Pediatr Pulmonol. 2023;58:2857-2864.
    PubMed     Abstract available


  123. SHANTHIKUMAR S, Ruseckaite R, Corda J, Mulrennan S, et al
    Telehealth use in Australian cystic fibrosis centers: Clinician experiences.
    Pediatr Pulmonol. 2023;58:2906-2915.
    PubMed     Abstract available


  124. GALAMBOS C, Logan JW, Stankiewicz P, Szafranski P, et al
    Histologic features and decreased lung FOXF1 gene expression in severe bronchopulmonary dysplasia without a genetic diagnosis of alveolar capillary dysplasia.
    Pediatr Pulmonol. 2023;58:2746-2749.
    PubMed     Abstract available


    September 2023
  125. SHANDIL A, Bhatia A, Mathew JL, Saxena AK, et al
    Unilateral bilobar pulmonary aplasia with anomalous pulmonary venous return: A rare combination of congenital airway and vascular anomalies.
    Pediatr Pulmonol. 2023 Sep 20. doi: 10.1002/ppul.26697.
    PubMed    


  126. STALKER HJ, Jonasson AR, Hopfer SM, Collins MS, et al
    Improvement in cystic fibrosis newborn screening program outcomes with genetic counseling via telemedicine.
    Pediatr Pulmonol. 2023 Sep 15. doi: 10.1002/ppul.26678.
    PubMed     Abstract available


  127. LI H, Huang Z, Yang C, Han D, et al
    Association between plasma lysophosphatidic acid levels and bronchopulmonary dysplasia in extremely preterm infants: A prospective study.
    Pediatr Pulmonol. 2023 Sep 15. doi: 10.1002/ppul.26685.
    PubMed     Abstract available


  128. HUANG Z, Cheng X, Lin B, Zhao J, et al
    Diameter of ductus arteriosus on postnatal Day 7 is associated with late pulmonary hypertension in extremely preterm infants.
    Pediatr Pulmonol. 2023 Sep 15. doi: 10.1002/ppul.26686.
    PubMed     Abstract available


  129. VITALE JL, DeMauro SB, Gibbs K, Kielt MJ, et al
    Clinician opinions on nasal versus oral intubation in infants with BPD: A multicenter survey.
    Pediatr Pulmonol. 2023 Sep 13. doi: 10.1002/ppul.26653.
    PubMed    


  130. COUSINS M, Hart K, Radics BL, Henderson AJ, et al
    Peripheral airway dysfunction in prematurity-associated obstructive lung disease identified by oscillometry.
    Pediatr Pulmonol. 2023 Sep 13. doi: 10.1002/ppul.26658.
    PubMed     Abstract available


  131. RUFFLES T, Inglis SK, Memon A, Seddon P, et al
    Environmental risk factors for respiratory infection and wheeze in young children: A multicentre birth cohort study.
    Pediatr Pulmonol. 2023 Sep 10. doi: 10.1002/ppul.26664.
    PubMed     Abstract available


  132. FINN E, Severn C, Pyle L, Garrish J, et al
    Hypoglycemia in children and young adults with cystic fibrosis during oral glucose tolerance testing vs. continuous glucose monitoring.
    Pediatr Pulmonol. 2023;58:2495-2504.
    PubMed     Abstract available


  133. EKBLOND RS, Nielsen BU, Hojte C, Almdal TP, et al
    Changes in glucose tolerance in people with cystic fibrosis after initiation of first-generation CFTR modulator treatment.
    Pediatr Pulmonol. 2023;58:2600-2609.
    PubMed     Abstract available


  134. HERGENROEDER GE, Faino AV, Cogen JD, Genatossio A, et al
    Seroprevalence and clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:2478-2486.
    PubMed     Abstract available


  135. DEPIAZZI J, Bourke C, Stick S, Withers A, et al
    Prevalence of tracheobronchomalacia is higher than previously reported in children with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:2568-2573.
    PubMed     Abstract available


  136. RICHARDS CJ, Friedman D, Pinsky H, Gootkind E, et al
    Alcohol and opiate misuse in adults with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:2535-2542.
    PubMed     Abstract available


  137. IFIKHAR J, Hendrix-Dicken AD, Kezbers KM, Stuemky L, et al
    Cystic fibrosis fitness during inpatient treatment (CF-FIT): A pre-post pilot study.
    Pediatr Pulmonol. 2023;58:2675-2677.
    PubMed    


  138. UYTUN S, Cinel G, Eryilmaz Polat S, Ozkan Tabakci S, et al
    Patients with cystic fibrosis who could not receive the CFTR modulator treatment: What did they lose in 1 year?
    Pediatr Pulmonol. 2023;58:2505-2512.
    PubMed     Abstract available


  139. BATHGATE CJ, Muther E, Georgiopoulos AM, Smith B, et al
    Positive and negative impacts of elexacaftor/tezacaftor/ivacaftor: Healthcare providers' observations across US centers.
    Pediatr Pulmonol. 2023;58:2469-2477.
    PubMed     Abstract available


    August 2023
  140. PUGH CP, Ali S, Agarwal A, Matlock DN, et al
    Dynamic computed tomography for evaluation of tracheobronchomalacia in premature infants with bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2023 Aug 30. doi: 10.1002/ppul.26652.
    PubMed     Abstract available


  141. OZDEMIR FE, Alan S, Aliefendioglu D
    The diagnostic value of pulmonary near-infrared spectroscopy in the early distinction of neonatal pneumonia from transient tachypnea of the newborn.
    Pediatr Pulmonol. 2023 Aug 30. doi: 10.1002/ppul.26656.
    PubMed     Abstract available


  142. HAGMAN C, Bjorklund LJ, Bjermer L, Hansen-Pupp I, et al
    Lung function deficits and bronchodilator responsiveness at 12 years of age in children born very preterm compared with controls born at term.
    Pediatr Pulmonol. 2023 Aug 18. doi: 10.1002/ppul.26636.
    PubMed     Abstract available


  143. CORREANI A, Lanciotti L, Giorgetti C, Palazzi ML, et al
    Reduced pulmonary oxygen diffusion at 36 weeks of postmenstrual age in small-for-gestational-age preterm infants of less than 32 weeks without bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2023 Aug 18. doi: 10.1002/ppul.26620.
    PubMed     Abstract available


  144. SMITH EF, Bradshaw TK, Urs RC, Evans DJ, et al
    Oscillometry and spirometry are not interchangeable when assessing the bronchodilator response in children and young adults born preterm.
    Pediatr Pulmonol. 2023 Aug 4. doi: 10.1002/ppul.26632.
    PubMed     Abstract available


  145. DEY R, Sardar SK, Kumar Saha A, Mukherjee S, et al
    Nonsynchronized nasal intermittent positive pressure ventilation versus continuous positive airway pressure as a primary mode of respiratory support in neonates (26-40 weeks) admitted in a tertiary care center: A randomized controlled trial.
    Pediatr Pulmonol. 2023 Aug 2. doi: 10.1002/ppul.26624.
    PubMed     Abstract available


  146. GUPTA R, Bandyopadhyay T, Yadav B, Guleria M, et al
    Sonographic assessment of diaphragmatic thickness and excursion to predict CPAP failure in neonates below 34 weeks of gestation: A prospective cohort study.
    Pediatr Pulmonol. 2023 Aug 2. doi: 10.1002/ppul.26608.
    PubMed     Abstract available


  147. SISMANLAR EYUBOGLU T, Aslan AT, Asfuroglu P, Kunt N, et al
    Neutrophil lymphocyte ratio, mean platelet volume, and immunoreactive trypsinogen as early inflammatory biomarkers for cystic fibrosis in infancy: A retrospective cohort study.
    Pediatr Pulmonol. 2023 Aug 2. doi: 10.1002/ppul.26628.
    PubMed     Abstract available


  148. GOETZ DM, Frederick CK, Perez G, Borowitz D, et al
    Airway clearance after highly effective CFTR modulators: Normalizing life and reducing treatment burden.
    Pediatr Pulmonol. 2023;58:2375-2380.
    PubMed     Abstract available


  149. SOUTH K, Smaldone A, Sadeghi H, Piane V, et al
    Parent and adolescent perceptions of cystic fibrosis management responsibility: A mixed-methods study.
    Pediatr Pulmonol. 2023;58:2340-2351.
    PubMed     Abstract available


  150. GUSHUE C, Eisner M, Bai S, Johnson T, et al
    Impact of Elexacaftor-Tezacaftor-Ivacaftor on lung disease in cystic fibrosis.
    Pediatr Pulmonol. 2023;58:2308-2316.
    PubMed     Abstract available


  151. PALLA J, Thapa S, Venkatachalam A, Runge JK, et al
    The upper airway microbiome in Hispanic children with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:2298-2307.
    PubMed     Abstract available


  152. AALBERS BL, Mohamed Hoesein FAA, Hofland RW, Bronsveld I, et al
    Radiological and long-term clinical response to elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease.
    Pediatr Pulmonol. 2023;58:2317-2322.
    PubMed     Abstract available


  153. DAY RW, Lai KV, Baisch HN, Lau IC, et al
    Descriptive images and features of pulmonary vascular disease in a child with a FOXF1 variant.
    Pediatr Pulmonol. 2023;58:2383-2385.
    PubMed    


  154. SOHOULI MH, Magalhaes EIDS, Ghahramani S, Nasresfahani M, et al
    Impact of omega-3 supplementation on children and adolescents patients with cystic fibrosis: A systematic review and meta-analysis of randomized-controlled trials.
    Pediatr Pulmonol. 2023;58:2219-2228.
    PubMed     Abstract available


  155. CORDA J, E Holland A, Berry CD, Westrupp N, et al
    Validation of the 25 level modified shuttle test in children with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:2240-2248.
    PubMed     Abstract available


    July 2023
  156. ROCK MJ, Baker M, Farrell PM
    Cystic fibrosis screen-positive neonates with one pathogenic variant still warrant sweat testing.
    Pediatr Pulmonol. 2023 Jul 28. doi: 10.1002/ppul.26621.
    PubMed    


  157. ABE J, Ueki M, Honjou R, Takeda K, et al
    The clinical importance of pulmonary gene and protein expression levels in an infant with lethal ABCA3 variants.
    Pediatr Pulmonol. 2023 Jul 21. doi: 10.1002/ppul.26611.
    PubMed    


  158. VILLAMIL-OSORIO M, Moyano-Ariza LF, Camacho-Moreno G, Restrepo-Gualteros SM, et al
    Multilevel analysis identifying the factors associated with RSV detection in infants admitted for viral bronchiolitis in the era of the COVID-19 pandemic.
    Pediatr Pulmonol. 2023 Jul 14. doi: 10.1002/ppul.26590.
    PubMed     Abstract available


  159. MOHSEN N, Solis-Garcia G, Jasani B, Nasef N, et al
    Accuracy of lung ultrasound in predicting extubation failure in neonates: A systematic review and meta-analysis.
    Pediatr Pulmonol. 2023 Jul 11. doi: 10.1002/ppul.26598.
    PubMed     Abstract available


  160. WU C, Fu J, Zhu X, Li H, et al
    Heart failure due to pulmonary sequestration in an infant.
    Pediatr Pulmonol. 2023 Jul 11. doi: 10.1002/ppul.26596.
    PubMed    


  161. PERRI A, Sbordone A, Patti ML, Nobile S, et al
    The future of neonatal lung ultrasound: Validation of an artificial intelligence model for interpreting lung scans. A multicentre prospective diagnostic study.
    Pediatr Pulmonol. 2023 Jul 7. doi: 10.1002/ppul.26563.
    PubMed     Abstract available


  162. VERKLEIJ M, Georgiopoulos AM, Barendrecht H, Friedman D, et al
    Pilot of a therapist-guided digital mental health intervention (eHealth CF-CBT) for adults with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:2094-2103.
    PubMed     Abstract available


  163. TERLIZZI V, Fevola C, Ferrari B, Castellani C, et al
    Lung clearance index in children with cystic fibrosis previously diagnosed with CRMS/CFSPID: A monocentric prospective experience.
    Pediatr Pulmonol. 2023;58:2124-2131.
    PubMed     Abstract available


  164. FOSTER C, Noreen P, Grage J, Kwon S, et al
    Predictors for invasive home mechanical ventilation duration in bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2023;58:2085-2093.
    PubMed     Abstract available


  165. WARD A, Mauleon R, Arellano J, Ooi CY, et al
    Critical disease burdens of Australian adults with cystic fibrosis: Results from an online survey.
    Pediatr Pulmonol. 2023;58:1931-1941.
    PubMed     Abstract available


  166. KIMBALL H, Cobham VE, Sanders M, Douglas T, et al
    Procedural anxiety among children and adolescents with cystic fibrosis and their parents.
    Pediatr Pulmonol. 2023;58:1967-1976.
    PubMed     Abstract available


  167. PRIYADARSHI M, Sankar MJ
    Lung ultrasound for surfactant replacement: Methodological concerns.
    Pediatr Pulmonol. 2023;58:1864-1865.
    PubMed    


  168. FEIN V, Maier C, Schlegtendal A, Denz R, et al
    Risk factors for the deterioration of pulmonary function in primary ciliary dyskinesia.
    Pediatr Pulmonol. 2023;58:1950-1958.
    PubMed     Abstract available


  169. HUNTER-SCHOUELA J, Geraghty MT, Hegele RA, Dyment DA, et al
    First reports of primary ciliary dyskinesia caused by a shared DNAH11 allele in Canadian Inuit.
    Pediatr Pulmonol. 2023;58:1942-1949.
    PubMed     Abstract available


  170. NOIJ L, Haarman E, Hashimoto S, Terheggen-Lagro S, et al
    Depression, anxiety, and resilience during COVID-19 in Dutch patients with cystic fibrosis or primary ciliary dyskinesia and their caregivers.
    Pediatr Pulmonol. 2023;58:2025-2034.
    PubMed     Abstract available


    June 2023
  171. MENG CY, Zou JZ, Wang Y, Wei YD, et al
    Pathological findings in congenital diaphragmatic hernia on necropsy studies: A single-center case series.
    Pediatr Pulmonol. 2023 Jun 28. doi: 10.1002/ppul.26565.
    PubMed     Abstract available


  172. VIVALDA L, Loi B, Bisceglie V, Ben-Ammar R, et al
    Effect of preterm chorioamnionitis on lung ultrasound score used to guide surfactant replacement.
    Pediatr Pulmonol. 2023 Jun 28. doi: 10.1002/ppul.26576.
    PubMed     Abstract available


  173. LAVIZZARI A, Zannin E, Klotz D, Dassios T, et al
    State of the art on neonatal noninvasive respiratory support: How physiological and technological principles explain the clinical outcomes.
    Pediatr Pulmonol. 2023 Jun 28. doi: 10.1002/ppul.26561.
    PubMed     Abstract available


  174. KRISHNANANTHAN T, Britton PN, Wong M, Selvadurai H, et al
    COVID-19 complicated by postinfectious bronchiolitis obliterans and pulmonary aspergillosis in an infant.
    Pediatr Pulmonol. 2023 Jun 23. doi: 10.1002/ppul.26572.
    PubMed    


  175. AOYAMA BC, McGrath-Morrow SA, Psoter KJ, Collaco JM, et al
    Patterns of early life somatic growth in infants and children with a history of chronic lung disease of prematurity.
    Pediatr Pulmonol. 2023 Jun 23. doi: 10.1002/ppul.26560.
    PubMed     Abstract available


  176. TSUKAHARA K, Scully T, McDonough J, Boas H, et al
    Reactance inversion in a cohort of former preterms: Physiology or artifact?
    Pediatr Pulmonol. 2023 Jun 21. doi: 10.1002/ppul.26553.
    PubMed    


  177. KIPFMUELLER F, Bo B, Schmitt J, Sabir H, et al
    Percutaneous, ultrasound-guided single- and multisite cannulation for veno-venous extracorporeal membrane oxygenation in neonates.
    Pediatr Pulmonol. 2023 Jun 14. doi: 10.1002/ppul.26555.
    PubMed     Abstract available


  178. HU H, Jing X, Duan X, Zhou L, et al
    Congenital diaphragmatic hernia.
    Pediatr Pulmonol. 2023 Jun 14. doi: 10.1002/ppul.26542.
    PubMed     Abstract available


  179. CHEN Y, Zhang Y
    Extremely thinning ribs in severe congenital myopathy.
    Pediatr Pulmonol. 2023 Jun 14. doi: 10.1002/ppul.26547.
    PubMed     Abstract available


  180. SHEN J, Du Y, Sun Y, Huang X, et al
    Modified lung ultrasound score for bronchopulmonary dysplasia predicts late respiratory outcomes in preterm infants.
    Pediatr Pulmonol. 2023 Jun 9. doi: 10.1002/ppul.26546.
    PubMed     Abstract available


  181. LUSTEAU A, Valla F, Javouhey E, Baudin F, et al
    Hypophosphatemia in infants with severe bronchiolitis and association with length of mechanical ventilation.
    Pediatr Pulmonol. 2023 Jun 6. doi: 10.1002/ppul.26538.
    PubMed     Abstract available


  182. MARCELINO M, Cai CL, Wadowski S, Aranda JV, et al
    Biomarkers of lung alveolarization and microvascular maturation in response to intermittent hypoxia and/or early antioxidant/fish oil supplementation in neonatal rats.
    Pediatr Pulmonol. 2023 Jun 2. doi: 10.1002/ppul.26495.
    PubMed     Abstract available


  183. ZONG H, Huang Y, Huang Z, Zhao J, et al
    Lung ultrasound score predicts patent ductus arteriosus ligation among neonates
    Pediatr Pulmonol. 2023 Jun 2. doi: 10.1002/ppul.26531.
    PubMed     Abstract available


  184. KIELT MJ, Hatch LD 3rd, Levin JC, Napolitano N, et al
    Classifying multicenter approaches to invasive mechanical ventilation for infants with bronchopulmonary dysplasia using hierarchical clustering analysis.
    Pediatr Pulmonol. 2023 Jun 2. doi: 10.1002/ppul.26488.
    PubMed     Abstract available


  185. CHIN D, Ramalingam L, Harrison J, Silva M, et al
    Oral health and cystic fibrosis in pediatrics: A survey of health professionals.
    Pediatr Pulmonol. 2023;58:1746-1752.
    PubMed     Abstract available


  186. SALLIH ASM, Wee MW, Zaki RA, Hng SY, et al
    The outcome of COVID-19 in children with chronic lung disease: Systematic review and meta-analyses.
    Pediatr Pulmonol. 2023;58:1784-1797.
    PubMed     Abstract available


  187. QUITTNER AL, Barker D, Graziano S, Georgiopoulos AM, et al
    National integration of mental health screening and treatment into specialized care for cystic fibrosis: What predicts success?
    Pediatr Pulmonol. 2023;58:1768-1776.
    PubMed     Abstract available


  188. RAISSI G, Messier R, Sadeghi D, Sadeghi H, et al
    CF Bridge of Hope program, a global medical home practice.
    Pediatr Pulmonol. 2023;58:1802-1804.
    PubMed    


  189. GRANADOS A, Chan CL, Moheet A, Vigers T, et al
    The impact of elexacaftor/tezacaftor/ivacaftor on body composition in a small cohort of youth with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:1805-1811.
    PubMed     Abstract available


  190. PERKINS RC, Sawicki GS
    High deductible insurance plans impart economic burden for people with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:1798-1801.
    PubMed    


    May 2023
  191. HON KLE, Hui CMP, Fung GPG, Leung KKY, et al
    Hypertonic glucose pleurodesis for preterm neonates with chylothorax.
    Pediatr Pulmonol. 2023 May 12. doi: 10.1002/ppul.26436.
    PubMed     Abstract available


  192. WU S, Ryan RM, Auten RL
    2022 Year in review: Neonatal pulmonology.
    Pediatr Pulmonol. 2023 May 12. doi: 10.1002/ppul.26468.
    PubMed     Abstract available


  193. KOJIMA M, Touge R, Kurihara S, Saeki I, et al
    Transthoracic puncture for asymptomatic congenital pulmonary airway malformation during anesthesia.
    Pediatr Pulmonol. 2023 May 10. doi: 10.1002/ppul.26469.
    PubMed    


  194. DANI C, Fusco M, Manti S, Marseglia L, et al
    Effects of caffeine on diaphragmatic activity in preterm infants.
    Pediatr Pulmonol. 2023 May 5. doi: 10.1002/ppul.26439.
    PubMed     Abstract available


  195. HARRIS C, Lunt A, Peacock J, Greenough A, et al
    Lung function at 16-19 years in males and females born very prematurely.
    Pediatr Pulmonol. 2023 May 5. doi: 10.1002/ppul.26428.
    PubMed     Abstract available


  196. CALLAWAY DA, Wang Y, Lingappan K, Pogoriler JE, et al
    Lung biopsy in infants with severe bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2023 May 3. doi: 10.1002/ppul.26433.
    PubMed     Abstract available


  197. CHOOBDAR FA, Shahhosseini P, Vahedi Z, Khosravi N, et al
    Comparison of the efficacy of inhaled versus infused milrinone in the management of persistent pulmonary hypertension of the newborn in resource-limited settings: A randomized clinical trial.
    Pediatr Pulmonol. 2023 May 3. doi: 10.1002/ppul.26451.
    PubMed     Abstract available


  198. BU X, Sun P, Wan Y
    Meconium thorax observed in a Chinese neonate with cystic fibrosis.
    Pediatr Pulmonol. 2023 May 3. doi: 10.1002/ppul.26443.
    PubMed    


  199. DACCO V, Alicandro G, Consales A, Rosazza C, et al
    Cepacia syndrome in cystic fibrosis: A systematic review of the literature and possible new perspectives in treatment.
    Pediatr Pulmonol. 2023;58:1337-1343.
    PubMed     Abstract available


  200. SALAH S, Rumman N, Nassar A, Khdour M, et al
    Clinical characteristics and outcomes of cystic fibrosis in Palestine: Cross sectional study.
    Pediatr Pulmonol. 2023;58:1574-1581.
    PubMed     Abstract available


  201. STRANSKY OM, Benipal S, Pam M, Taylor-Cousar JL, et al
    "Find ways to work parenting into cystic fibrosis": A PhotoVoice exploration of being a parent and having CF.
    Pediatr Pulmonol. 2023;58:1527-1534.
    PubMed     Abstract available


  202. BECK MR, Hornick DB, Pena TA, Singh SB, et al
    Impact of elexacaftor/tezacaftor/ivacaftor on bacterial cultures from people with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:1569-1573.
    PubMed     Abstract available


  203. MCGLYNN JR, Aoyama BC, Martin A, Collaco JM, et al
    Outpatient respiratory outcomes in children with BPD on supplemental oxygen.
    Pediatr Pulmonol. 2023;58:1535-1541.
    PubMed     Abstract available


  204. COLLACO JM, Li Y, Rhein LM, Tracy MC, et al
    Validation of an outpatient questionnaire for bronchopulmonary dysplasia control.
    Pediatr Pulmonol. 2023;58:1551-1561.
    PubMed     Abstract available


  205. GECILI E, Brokamp C, Rasnick E, Afonso PM, et al
    Built environment factors predictive of early rapid lung function decline in cystic fibrosis.
    Pediatr Pulmonol. 2023;58:1501-1513.
    PubMed     Abstract available


  206. WALLACE K, Devenny A, Azam T, Langley RJ, et al
    Novel cystic fibrosis transmembrane conductance (CFTR) variant in a patient with Ghanaian parentage.
    Pediatr Pulmonol. 2023;58:1611-1613.
    PubMed    


  207. KLEEBAYOON A, Wiwanitkit V
    Correspondence on acceptability of COVID-19 vaccination with bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2023;58:1610.
    PubMed    


  208. BEDOYA M, Salfinger M, Weisman A, Colin AA, et al
    Culture result discrepancy between laboratories for nontuberculous mycobacteria in people with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:1598-1601.
    PubMed    


  209. GOKDEMIR Y, Eralp EE, Ergenekon AP, Yegit CY, et al
    Improvements in body mass index of children with cystic fibrosis following implementation of a standardized nutritional algorithm: A quality improvement project.
    Pediatr Pulmonol. 2023;58:1463-1470.
    PubMed     Abstract available


  210. MCGARRY ME, Gibb ER, Laguna TA, O'Sullivan BP, et al
    How many billions is enough? Prioritizing profits over patients with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:1595-1597.
    PubMed    


  211. DE VUYST RC, Bennard E, Kam CW, McKinzie CJ, et al
    Elexacaftor/tezacaftor/ivacaftor treatment reduces airway inflammation in cystic fibrosis.
    Pediatr Pulmonol. 2023;58:1592-1594.
    PubMed    


  212. WANG D, Li L, Cao J, Hu S, et al
    Acceptability of COVID-19 vaccination in Chinese children aged 3-7 years with bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2023;58:1417-1426.
    PubMed     Abstract available


    April 2023
  213. HILDE K, Gudmundsdottir HK, Bains KES, Carlsen KCL, et al
    Third trimester fetal lung volume, thoracic circumference, and early infant lung function.
    Pediatr Pulmonol. 2023 Apr 26. doi: 10.1002/ppul.26431.
    PubMed     Abstract available


  214. KOUSSA S, Dombkowski A, Cukovic D, Poulik J, et al
    MicroRNA dysregulation in the heart and lung of infants with bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2023 Apr 26. doi: 10.1002/ppul.26422.
    PubMed     Abstract available


  215. ADLER-HALTOVSKY T, Gileles-Hillel A, Erlichman I, Eventov-Friedman S, et al
    Changes in ventilation modes in the last decade and their impact on the prevalence of bronchopulmonary dysplasia in preterm infants.
    Pediatr Pulmonol. 2023 Apr 21. doi: 10.1002/ppul.26418.
    PubMed     Abstract available


  216. GUPTA D, Greenberg RG, Natarajan G, Jani S, et al
    Association of patent ductus arteriosus with extubation failure among preterm infants.
    Pediatr Pulmonol. 2023 Apr 21. doi: 10.1002/ppul.26420.
    PubMed     Abstract available


  217. PRAPROTNIK M, Stucin Gantar I, Krivec U, Lucovnik M, et al
    Physical fitness trajectories from childhood to adolescence in extremely preterm children: A longitudinal cohort study.
    Pediatr Pulmonol. 2023 Apr 10. doi: 10.1002/ppul.26410.
    PubMed     Abstract available


  218. GHELAB Z, Bokov P, Teissier N, Micaelli D, et al
    Decannulation in congenital central hypoventilation syndrome.
    Pediatr Pulmonol. 2023 Apr 4. doi: 10.1002/ppul.26399.
    PubMed     Abstract available


  219. EASTWOOD-SUTHERLAND C, Lim K, Gale TJ, Wheeler KI, et al
    Detection of respiratory activity in newborn infants using a noncontact vision-based monitor.
    Pediatr Pulmonol. 2023 Apr 4. doi: 10.1002/ppul.26397.
    PubMed     Abstract available


  220. GOUSSARD P, van der Westhuizen S, Venkatakrishna S, Andronikou S, et al
    Foregut duplication cyst presenting at birth with airway compression.
    Pediatr Pulmonol. 2023 Apr 4. doi: 10.1002/ppul.26398.
    PubMed    


  221. WYNTER Z, Pham Q, Mundy C, Walters C, et al
    Acquired lobar emphysema: A complication of severe bronchopulmonary dysplasia needing lobectomy.
    Pediatr Pulmonol. 2023 Apr 4. doi: 10.1002/ppul.26402.
    PubMed    


  222. SMITH MA, Steurer MA, Mahendra M, Zinter MS, et al
    Sociodemographic factors associated with tracheostomy and mortality in bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2023;58:1237-1246.
    PubMed     Abstract available


  223. NAYIR BUYUKSAHIN H, Dogru D, Emiralioglu N, Ademhan Tural D, et al
    A case-control study of the effects of Aspergillus clinical phenotypes on pulmonary functions in patients with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:1185-1193.
    PubMed     Abstract available


  224. TOSCO A, Carnovale V, Claut L, Fabrizzi B, et al
    Clinical outcome of individuals carrying 5T;TG12 in trans with CFTR variants with varying clinical consequences.
    Pediatr Pulmonol. 2023;58:1253-1255.
    PubMed    


  225. MCCOY KS, Blind J, Johnson T, Olson P, et al
    Clinical change 2 years from start of elexacaftor-tezacaftor-ivacaftor in severe cystic fibrosis.
    Pediatr Pulmonol. 2023;58:1178-1184.
    PubMed     Abstract available


  226. WANG A, Armstrong DS, Nixon GM
    High rates of procedure-related pain and anxiety in children with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:1247-1249.
    PubMed    


  227. CLARKE E, Moore F, Gallagher A, Thomson S, et al
    The impact of CFTR modulators on bone health.
    Pediatr Pulmonol. 2023;58:1256.
    PubMed    


  228. PASLEY K, Krivchenia K, Dell ML, McCoy KS, et al
    Clinical management of pediatric patients with cystic fibrosis and autism spectrum disorder.
    Pediatr Pulmonol. 2023;58:1160-1168.
    PubMed     Abstract available


  229. ZOBELL JT, Moss J, Creelman J, Christensen R, et al
    Implementation of a comprehensive pharmacy-driven immunization care process model in a pediatric cystic fibrosis clinic.
    Pediatr Pulmonol. 2023;58:1145-1151.
    PubMed     Abstract available


  230. RIGGSBEE D, Engdahl S, Pettit RS
    Evaluation of the safety of piperacillin-tazobactam extended infusion in pediatric cystic fibrosis patients.
    Pediatr Pulmonol. 2023;58:1092-1099.
    PubMed     Abstract available


  231. CHADWICK C, Arcinas R, Ham M, Huang R, et al
    The use of DXA for early detection of pediatric cystic fibrosis-related bone disease.
    Pediatr Pulmonol. 2023;58:1136-1144.
    PubMed     Abstract available


  232. SALINAS DB, Ginsburg DK, Wee CP, Saeed MM, et al
    Gradual increase in sweat chloride concentration is associated with a higher risk of CRMS/CFSPID to CF reclassification.
    Pediatr Pulmonol. 2023;58:1074-1084.
    PubMed     Abstract available


    March 2023
  233. BALAJTHY A, Balazs G, Kovacs T, Belteki G, et al
    Synchronized intermittent mandatory ventilation with volume guarantee and pressure support in neonates: Detailed analysis of ventilator parameters.
    Pediatr Pulmonol. 2023 Mar 17. doi: 10.1002/ppul.26384.
    PubMed     Abstract available


  234. BO B, Pugnaloni F, Licari A, Patel N, et al
    Ductus arteriosus flow predicts outcome in neonates with congecsion.
    Pediatr Pulmonol. 2023 Mar 15. doi: 10.1002/ppul.26385.
    PubMed     Abstract available


  235. MCKINNEY RL, Agarwal A
    Transition from intensive care unit to a portable ventilator in children with severe bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2023;58:712-719.
    PubMed     Abstract available


  236. SAKON C, Vogt H, Brown CD, Tillman EM, et al
    A survey assessing the impact of COVID-19 and elexacaftor/tezacaftor/ifavacaftor on both physical and mental health in adults with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:662-664.
    PubMed     Abstract available


  237. GONZALEZ-ROSALES N, Kasi AS, McCracken CE, Silva GL, et al
    Impact of viral respiratory infections on pulmonary exacerbations in children with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:871-877.
    PubMed     Abstract available


  238. SATHE M, Moshiree B, Aliaj E, Lee M, et al
    Need to study simplification of gastrointestinal medication regimen in cystic fibrosis in the era of highly effective modulators.
    Pediatr Pulmonol. 2023;58:811-818.
    PubMed     Abstract available


  239. SHEIKH S, Britt RD Jr, Ryan-Wenger NA, Khan AQ, et al
    Impact of elexacaftor-tezacaftor-ivacaftor on bacterial colonization and inflammatory responses in cystic fibrosis.
    Pediatr Pulmonol. 2023;58:825-833.
    PubMed     Abstract available


  240. SRIVATSA B, Srivatsa KR, Clark RH
    Assessment of validity and utility of a bronchopulmonary dysplasia outcome estimator.
    Pediatr Pulmonol. 2023;58:788-793.
    PubMed     Abstract available


  241. LOPES J, Vidal-Folch N, Lundquist P, Schimmenti LA, et al
    Aminoglycoside induced ototoxicity risk in the cystic fibrosis population: The utility of large-scale screening.
    Pediatr Pulmonol. 2023;58:819-824.
    PubMed     Abstract available


  242. SAVANT AP, McColley SA
    Cystic fibrosis year in review 2019: Section 3 multisystem-based care and research.
    Pediatr Pulmonol. 2023;58:697-703.
    PubMed     Abstract available


  243. SAVANT AP, McColley SA
    Cystic fibrosis year in review 2019: Section 2 pulmonary disease and infections.
    Pediatr Pulmonol. 2023;58:672-682.
    PubMed     Abstract available


    February 2023
  244. ROSE P, Rana S, Abbey C, Deskins S, et al
    Congenital Lobar Emphysema: A rare cause of respiratory failure in neonates.
    Pediatr Pulmonol. 2023 Feb 28. doi: 10.1002/ppul.26376.
    PubMed     Abstract available


  245. MONTERO GATO J, Sacristan PA, Vazquez NL, Martin MLH, et al
    Incidence of ultrasonographic signs of pneumothorax in asymptomatic neonates.
    Pediatr Pulmonol. 2023 Feb 27. doi: 10.1002/ppul.26378.
    PubMed     Abstract available


  246. STICKNEY CA, Levy PT, Abecassis L, Levin JC, et al
    Beyond the NICU: Comprehensive management of infants with bronchopulmonary dysplasia in the PICU.
    Pediatr Pulmonol. 2023 Feb 24. doi: 10.1002/ppul.26364.
    PubMed    


  247. GATT D, Lapidus-Krol E, Chiu PPL
    The Long-Term Outcomes of Symptomatic Congenital Lobar Emphysema Patients.
    Pediatr Pulmonol. 2023 Feb 23. doi: 10.1002/ppul.26354.
    PubMed     Abstract available


  248. DREYFUS L, Butin M, Plaisant F, Claris O, et al
    Respiratory physiology during NAVA ventilation in neonates born with a congenital diaphragmatic hernia: the "NAVA-diaph" pilot study.
    Pediatr Pulmonol. 2023 Feb 17. doi: 10.1002/ppul.26357.
    PubMed     Abstract available


  249. CARR K, Wang H, Bedoya M
    Type I pleuropulmonary blastoma incidentally diagnosed in an infant with RSV bronchiolitis.
    Pediatr Pulmonol. 2023 Feb 17. doi: 10.1002/ppul.26363.
    PubMed    


  250. DANAN C, Tauzin M, Jung C, Carbonnier B, et al
    Instrumental dead space: a glass ceiling for extremely low birth weight preterm infants? A dead space washout bench study.
    Pediatr Pulmonol. 2023 Feb 13. doi: 10.1002/ppul.26353.
    PubMed     Abstract available


  251. ROEPER R, Blinder H, Hayawi L, Barrowman N, et al
    Physical activity levels, pulmonary function, and MRI in children born extremely preterm: a comparison between children with and without bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2023 Feb 7. doi: 10.1002/ppul.26351.
    PubMed     Abstract available


  252. MILES KG, Powell AW, Critser P, Hardie W, et al
    Long-term exercise and pulmonary function outcomes in a contemporary cohort of children with congenital diaphragmatic hernia.
    Pediatr Pulmonol. 2023 Feb 7. doi: 10.1002/ppul.26348.
    PubMed     Abstract available


  253. STIBOY E, Chan M, Islam MS, Saravanos GL, et al
    Variation in clinical practice guidelines for use of palivizumab in preventing severe respiratory syncytial viral (RSV) disease in high-risk infants.
    Pediatr Pulmonol. 2023 Feb 7. doi: 10.1002/ppul.26324.
    PubMed     Abstract available


  254. ZANNIN E, Stoecklin B, Choi JY, Simpson SJ, et al
    Ventilatory response and stability of oxygen saturation during a hypoxic challenge in very preterm infants.
    Pediatr Pulmonol. 2023 Feb 7. doi: 10.1002/ppul.26343.
    PubMed     Abstract available


  255. GUR M, Bar-Yoseph R, Hanna M, Abboud D, et al
    Effect of Trikafta on bone density, body composition and exercise capacity in CF: A pilot study.
    Pediatr Pulmonol. 2023;58:577-584.
    PubMed     Abstract available


  256. SANTHANAM P, Egberg M, Kappelman MD
    Higher mortality rates associated with Clostridioides difficile infection in hospitalized children with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:484-491.
    PubMed     Abstract available


  257. SU Y, Tang Y, Tang X, Shen Y, et al
    Case report of a pediatric Chinese cystic fibrosis patient with the c.1521_1523delCTT/c.3874-4522A>G genotype.
    Pediatr Pulmonol. 2023;58:556-558.
    PubMed     Abstract available


  258. INCE HY, Phan H, Nasr SZ, Pierce JM, et al
    Clearing up the smoke: Physical and mental health considerations regarding cannabis use in adolescents with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:398-407.
    PubMed     Abstract available


  259. BUSTAMANTE AE, Fernandez LT, Rivas LC, Mercado-Longoria R, et al
    Cystic fibrosis-related mortality trends in Mexico between 1999 and 2020.
    Pediatr Pulmonol. 2023;58:632-634.
    PubMed    


  260. AOYAMA BC, McGrath-Morrow SA, Collaco JM
    Socioeconomic status and outpatient follow-up in children with bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2023;58:623-626.
    PubMed    


  261. TURKER E, Sener S, Guzelkas I, Emiralioglu N, et al
    Immunoglobulin A vasculitis in a child: Secondary to COVID-19 or cystic fibrosis?
    Pediatr Pulmonol. 2023;58:627-628.
    PubMed    


  262. ORUM MB, Ronsholt FF, Jeppesen M, Bendstrup E, et al
    Outcome of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis and solid organ transplantation.
    Pediatr Pulmonol. 2023;58:602-605.
    PubMed     Abstract available


  263. GILELES-HILLEL A, Yochi Harpaz L, Breuer O, Reiter J, et al
    The clinical yield of bronchoscopy in the management of cystic fibrosis: A retrospective multicenter study.
    Pediatr Pulmonol. 2023;58:500-506.
    PubMed     Abstract available


  264. BOAT T, Hente E, Hardie W, Szczesniak R, et al
    Body composition and functional correlates of CF youth experiencing pulmonary exacerbation and recovery.
    Pediatr Pulmonol. 2023;58:457-464.
    PubMed     Abstract available


    January 2023
  265. WEI YJ, Ju YT, Hsieh ML, Kan CD, et al
    Surgical ligation, not transcatheter closure, associated with a higher severity of bronchopulmonary dysplasia in extremely preterm infant intervened for patent ductus arteriosus.
    Pediatr Pulmonol. 2023 Jan 25. doi: 10.1002/ppul.26325.
    PubMed     Abstract available


  266. ONG T, Bell S, Britto MT, Gamel B, et al
    Transforming the Nutrition Care Model for Infants with Cystic Fibrosis: a qualitative study of clinicians' perspectives.
    Pediatr Pulmonol. 2023 Jan 25. doi: 10.1002/ppul.26330.
    PubMed     Abstract available


  267. WANG J, Zhang A, Huang F, Xu J, et al
    MSC EXO and tempol ameliorate bronchopulmonary dysplasia in newborn rats by activating HIF-1alpha.
    Pediatr Pulmonol. 2023 Jan 17. doi: 10.1002/ppul.26317.
    PubMed     Abstract available


  268. WANG PY, Tseng WC, Wu ET, Lu FL, et al
    The Implications of Airway Anomalies on Children with Congenital Heart Disease and Bronchiolitis.
    Pediatr Pulmonol. 2023 Jan 17. doi: 10.1002/ppul.26320.
    PubMed     Abstract available


  269. SHANTAGIRI A, Prabhakar N, Bhatia A, Roy S, et al
    CONGENITAL LUNG MALFORMATIONS- SPOT ONE, HUNT FOR OTHERS.
    Pediatr Pulmonol. 2023 Jan 12. doi: 10.1002/ppul.26316.
    PubMed     Abstract available


  270. SATO S, Yamazaki S, Suzuki K, Kudo T, et al
    Cryptogenic organizing pneumonia in an infant.
    Pediatr Pulmonol. 2023 Jan 11. doi: 10.1002/ppul.26313.
    PubMed     Abstract available


  271. FRAUCHIGER BS, Ramsey KA, Usemann J, Kieninger E, et al
    Variability of clinically measured lung clearance index in children with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:197-205.
    PubMed     Abstract available


  272. MITCHELL B, Kormelink L, Kuhn R, Schadler A, et al
    Retrospective review of vancomycin monitoring via trough only versus two-point estimated area under the curve in pediatric and adult patients with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:239-245.
    PubMed     Abstract available


  273. ILGIN SISMAN H, Peker S, Gokdemir Y, Erdem Eralp E, et al
    Parent's report on oral health-related quality of life of children with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:246-252.
    PubMed     Abstract available


  274. FLYNN H, Wright B, Larson Ode K
    Assessing the occurrence of reproductive health counseling in adolescents with cystic fibrosis.
    Pediatr Pulmonol. 2023;58:332-335.
    PubMed    


  275. ZAMPOLI M, Verstraete J, Nguyen-Khoa T, Sermet-Gaudelus I, et al
    beta-adrenergic sweat test in children with inconclusive cystic fibrosis diagnosis: Do we need new reference ranges?
    Pediatr Pulmonol. 2023;58:187-196.
    PubMed     Abstract available


  276. NAYIR BUYUKSAHIN H, Emiralioglu N, Ademhan Tural D, Ozsezen B, et al
    Coexistence of cystic fibrosis with other genetic disorders: A case series.
    Pediatr Pulmonol. 2023;58:345-347.
    PubMed    


  277. SHORT C, Abkir M, Pinnell S, Proctor O, et al
    Migration is not the perfect answer: How the cross-talk error correction for multiple breath nitrogen washout (MBWN(2) ) parameters differs on directly collected vs. legacy data.
    Pediatr Pulmonol. 2023;58:328-331.
    PubMed     Abstract available


  278. CHO Y, Kwon Y, Ruth C, Cheng S, et al
    The burden of sleep disordered breathing in infants with Down syndrome referred to tertiary sleep center.
    Pediatr Pulmonol. 2023 Jan 1. doi: 10.1002/ppul.26302.
    PubMed     Abstract available


    December 2022
  279. MARCZAK H, Chrusciel J, Kulus M, Krenke K, et al
    COVID-19 in patients with persistent tachypnea of infancy.
    Pediatr Pulmonol. 2022 Dec 20. doi: 10.1002/ppul.26281.
    PubMed     Abstract available


  280. HORNE RS
    The natural history of obstructive sleep apnea in infancy.
    Pediatr Pulmonol. 2022 Dec 14. doi: 10.1002/ppul.26280.
    PubMed     Abstract available


  281. YEE AK, Siriwardhana LS, Nixon GM, Walter LM, et al
    Periodic breathing in clinically stable very preterm infants.
    Pediatr Pulmonol. 2022 Dec 12. doi: 10.1002/ppul.26273.
    PubMed     Abstract available


  282. REHANI MR, Marcus MS, Harris AB, Farrell PM, et al
    Variation in cystic fibrosis newborn screening algorithms in the United States.
    Pediatr Pulmonol. 2022 Dec 11. doi: 10.1002/ppul.26279.
    PubMed     Abstract available


  283. POLETTO S, Trevisanuto D, Ramaswamy VV, Seni AHA, et al
    Bubble CPAP respiratory support devices for infants in low-resource settings.
    Pediatr Pulmonol. 2022 Dec 9. doi: 10.1002/ppul.26258.
    PubMed     Abstract available


  284. DAVIS J, Ryan M, Marchetti P, Dahlberg SE, et al
    Real-world feasibility of short-term, unsupervised home spirometry in CF.
    Pediatr Pulmonol. 2022;57:3129-3135.
    PubMed     Abstract available


  285. SAHOO N, Dhochak N, Jat KR, Sankar J, et al
    Development of algorithm for diagnosis of cystic fibrosis in absence of sweat chloride testing in resource-limited setting.
    Pediatr Pulmonol. 2022;57:3077-3083.
    PubMed     Abstract available


  286. HATZIAGOROU E, Avramidou V, Gioulvanidou M, Talimtzi P, et al
    Pulmonary exacerbations, airway pathogens, and long-term course of lung clearance index in children and young adults with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:3069-3076.
    PubMed     Abstract available


  287. JENNINGS D, List R, Bruschwein H, Compton M, et al
    Social determinants of health screening and intervention: A cystic fibrosis quality improvement process.
    Pediatr Pulmonol. 2022;57:3035-3043.
    PubMed     Abstract available


  288. HATZIAGOROU E, Manika K, Kyrvasili SS, Kotoulas SC, et al
    Pulmonary medication adherence among children and adults with cystic fibrosis: Is there an association with disease severity?
    Pediatr Pulmonol. 2022;57:3017-3026.
    PubMed     Abstract available


  289. CORNET M, Robin G, Ciciriello F, Bihouee T, et al
    Profiling the response to lumacaftor-ivacaftor in children with cystic between fibrosis and new insight from a French-Italian real-life cohort.
    Pediatr Pulmonol. 2022;57:2992-2999.
    PubMed     Abstract available


  290. SUNMAN B, Yalcin E, Ozsezen B, Tural DA, et al
    Association between early chronic methicillin-susceptible Staphylococcus aureus colonization and lung function in children with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2963-2970.
    PubMed     Abstract available


  291. LYMAN BC, Seay J, Contreary C, Savant AP, et al
    Elexacaftor-tezacaftor-ivacaftor overdose in an adolescent female with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:3174-3176.
    PubMed    


    November 2022
  292. GAPP S, Garbade SF, Feyh P, Brockow I, et al
    German Newborn Screening for Cystic Fibrosis - Parental perspectives and suggestions for improvements.
    Pediatr Pulmonol. 2022 Nov 29. doi: 10.1002/ppul.26263.
    PubMed     Abstract available


  293. KUKKOLA HL, Kirjavainen T
    Obstructive sleep apnea in young infants: Sleep position dependence and spontaneous improvement.
    Pediatr Pulmonol. 2022 Nov 27. doi: 10.1002/ppul.26255.
    PubMed     Abstract available


  294. ZANNIN E, Rigotti C, Neumann RP, Dellaca RL, et al
    Oscillatory mechanics in very preterm infants on continuous positive airway pressure support: reference values.
    Pediatr Pulmonol. 2022 Nov 23. doi: 10.1002/ppul.26247.
    PubMed     Abstract available


  295. MISHRA A, Joshi A, Londhe A, Deshmukh L, et al
    Surfactant Administration in Preterm babies (28-36 weeks) with Respiratory Distress Syndrome: LISA vs InSurE, an Open-Label Randomized Controlled Trial.
    Pediatr Pulmonol. 2022 Nov 23. doi: 10.1002/ppul.26246.
    PubMed     Abstract available


  296. ROCK MJ, Baker M, Antos N, Farrell PM, et al
    REFINEMENT OF NEWBORN SCREENING FOR CYSTIC FIBROSIS WITH NEXT GENERATION SEQUENCING.
    Pediatr Pulmonol. 2022 Nov 23. doi: 10.1002/ppul.26253.
    PubMed     Abstract available


  297. AKANGIRE G, Lachica C, Noel-MacDonnell J, Begley A, et al
    Outcomes of Infants with Severe Bronchopulmonary Dysplasia Who Received Tracheostomy and Home Ventilation.
    Pediatr Pulmonol. 2022 Nov 14. doi: 10.1002/ppul.26248.
    PubMed     Abstract available


  298. WANG K, Zhou X, Gao S, Li F, et al
    Non-invasive high-frequency oscillatory ventilation vs nasal intermittent positive pressure ventilation for preterm infants as an extubation support: a systematic review and meta-analysis.
    Pediatr Pulmonol. 2022 Nov 13. doi: 10.1002/ppul.26244.
    PubMed     Abstract available


  299. CAI LM, Yao Y, Jiao AX, Zhang FZ, et al
    Circumferential subglottic hemangioma misdiagnosed twice in an infant with life-threatening dyspnea.
    Pediatr Pulmonol. 2022 Nov 9. doi: 10.1002/ppul.26228.
    PubMed     Abstract available


  300. GOTH FEM, Green K, Hansen BM, Agertoft L, et al
    From neonatal lung function to lung function and respiratory morbidity at 6-year follow-up.
    Pediatr Pulmonol. 2022 Nov 8. doi: 10.1002/ppul.26240.
    PubMed     Abstract available


  301. CAVIGIOLI F, Bresesti I, Di Peri A, Cerritelli F, et al
    Tidal volume optimization and heart rate response during stabilization of very preterm infants.
    Pediatr Pulmonol. 2022 Nov 2. doi: 10.1002/ppul.26229.
    PubMed     Abstract available


  302. MOHSEN N, Nasef N, Ghanem M, Yeung T, et al
    Accuracy of lung and diaphragm ultrasound in predicting successful extubation in extremely preterm infants: A prospective observational study.
    Pediatr Pulmonol. 2022 Nov 2. doi: 10.1002/ppul.26223.
    PubMed     Abstract available


  303. OZSIN-OZLER C, Duruel O, Pinar A, Ozbek B, et al
    Dental caries and associated salivary biomarkers in patients with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2839-2846.
    PubMed     Abstract available


  304. DACCO V, Sciarrabba CS, Corti F, Rosazza C, et al
    A successful treatment of a lobar atelectasis in a patient with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2868-2871.
    PubMed     Abstract available


  305. GILELES-HILLEL A, Soesman LH, Miari S, Breuer O, et al
    The utility of glucose area under the curve from the oral glucose tolerance test as a screening tool for cystic fibrosis-related diabetes.
    Pediatr Pulmonol. 2022;57:2774-2780.
    PubMed     Abstract available


  306. FRIEDMAN D, Smith BA, Bruce A, Schwartz CE, et al
    Feasibility and acceptability of a CF-specific cognitive-behavioral preventive intervention for adults integrated into team-based care.
    Pediatr Pulmonol. 2022;57:2781-2790.
    PubMed     Abstract available


  307. KASS AP, Berbert L, Dahlberg S, Bern E, et al
    Eating disorders in adolescents and young adults with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2791-2797.
    PubMed     Abstract available


  308. GUIMBELLOT JS, Ryan KJ, Anderson JD, Parker KL, et al
    Plasma and cellular ivacaftor concentrations in patients with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2745-2753.
    PubMed     Abstract available


  309. GRAZIANO S, Boldrini F, Quittner AL, Fiocchi AG, et al
    Stress and mental health in adolescents and young adults with cystic fibrosis 1 year after the COVID pandemic: Findings from an Italian sample.
    Pediatr Pulmonol. 2022;57:2707-2714.
    PubMed     Abstract available


  310. CAUSER AJ, Shute JK, Cummings MH, Shepherd AI, et al
    Elexacaftor-Tezacaftor-Ivacaftor improves exercise capacity in adolescents with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2652-2658.
    PubMed     Abstract available


  311. LINDLEY B, Bhakta Z, Gray K, Watanabe A, et al
    Pharmacokinetics of intermittent dosed intravenous vancomycin in adult persons with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2646-2651.
    PubMed     Abstract available


  312. SULEYMAN A, Tamay Z, Guler N
    Antibiotic allergy in children with cystic fibrosis: A retrospective case-control study.
    Pediatr Pulmonol. 2022;57:2622-2628.
    PubMed     Abstract available


  313. RAMASLI GURSOY T, Sismanlar Eyuboglu T, Aslan AT, Emiralioglu N, et al
    Psychological status of mothers of children with cystic fibrosis and primary ciliary dyskinesia.
    Pediatr Pulmonol. 2022;57:2665-2673.
    PubMed     Abstract available


  314. REEVES PT, Bennett WC, McCown MY, Welsh SK, et al
    The Cystic Fibrosis Action Plan: A low health literacy, pictographic self-management tool with clinical automation.
    Pediatr Pulmonol. 2022;57:2847-2850.
    PubMed    


    October 2022
  315. DAWSON SK, D'Andrea LA, Lagatta JM
    Management of diuretics in infants with bronchopulmonary dysplasia discharged on home oxygen.
    Pediatr Pulmonol. 2022 Oct 31. doi: 10.1002/ppul.26221.
    PubMed     Abstract available


  316. YANG W, Gao Y, Li P, Eckman MH, et al
    Should asymptomatic patients with congenital lung malformations undergo surgery? A decision analysis.
    Pediatr Pulmonol. 2022 Oct 17. doi: 10.1002/ppul.26206.
    PubMed     Abstract available


  317. MCGARRY ME, Ren CL, Wu R, Farrell PM, et al
    Detection of Disease-Causing CFTR Variants In State Newborn Screening Programs.
    Pediatr Pulmonol. 2022 Oct 13. doi: 10.1002/ppul.26209.
    PubMed     Abstract available


  318. SCHROEDER L, Kuelshammer M, Dolscheid-Pommerich R, Holdenrieder S, et al
    NT-proBNP and Zlog-transformed NT-proBNP values predict extubation failure in critically ill neonates with pulmonary hypertension and ventricular dysfunction.
    Pediatr Pulmonol. 2022 Oct 10. doi: 10.1002/ppul.26193.
    PubMed     Abstract available


  319. DEL PUPPO M, Meister L, Medale M, Allary C, et al
    Heliox simulations for initial management of congenital laryngotracheal stenosis.
    Pediatr Pulmonol. 2022 Oct 8. doi: 10.1002/ppul.26189.
    PubMed     Abstract available


  320. ALMUDARES F, Hagan J, Chen X, Devaraj S, et al
    Growth and differentiation factor 15 (GDF15) levels predict adverse respiratory outcomes in premature neonates.
    Pediatr Pulmonol. 2022 Oct 7. doi: 10.1002/ppul.26197.
    PubMed     Abstract available


  321. DOMINGO-ALEMAN P, Samperiz-Sinovas L, Martinez-Tourne A, Puertas-Martinez AI, et al
    Early-onset neonatal round pneumonia.
    Pediatr Pulmonol. 2022 Oct 6. doi: 10.1002/ppul.26192.
    PubMed     Abstract available


  322. JONSSON B, Drevhammar T, Donaldsson S
    Function of neonatal CPAP systems and the importance of total flow.
    Pediatr Pulmonol. 2022 Oct 5. doi: 10.1002/ppul.26195.
    PubMed     Abstract available


  323. ESCUDERO-AVILA R, Pecellin CD, Valera MJM, Hernandez LC, et al
    False negatives in the newborn screening for Cystic Fibrosis in Western Andalusia: Results from a 10- year experience.
    Pediatr Pulmonol. 2022 Oct 4. doi: 10.1002/ppul.26183.
    PubMed     Abstract available


  324. GOUSSARD P, Schubert P, Janson J, Naidoo S, et al
    "To the Editor" Recurrent wheezing caused by the combination of Bronchogenic Cyst and Congenital Lobar Emphysema in a young infant.
    Pediatr Pulmonol. 2022 Oct 4. doi: 10.1002/ppul.26181.
    PubMed     Abstract available


  325. WILSON LM, Potter A, Maher C, Ellis MJ, et al
    Feasibility of the A-STEP for the assessment of exercise capacity in people with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2524-2532.
    PubMed     Abstract available


  326. SHANTHIKUMAR S, Ranganathan S, Neeland MR
    Ivacaftor, not ivacaftor/lumacaftor, associated with lower pulmonary inflammation in preschool cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2549-2552.
    PubMed    


  327. NASR SZ, Gokdemir Y, Erdem E, Karakoc F, et al
    Collaboration between two CF centers; one in USA and one in Turkey before and during CoV2 pandemic.
    Pediatr Pulmonol. 2022;57:2553-2557.
    PubMed     Abstract available


  328. HUANG L, Lai HJ, Antos N, Rock MJ, et al
    Defining and identifying early-onset lung disease in cystic fibrosis with cumulative clinical characteristics.
    Pediatr Pulmonol. 2022;57:2363-2373.
    PubMed     Abstract available


  329. GUR M, Zuckerman-Levin N, Masarweh K, Hanna M, et al
    The effect of probiotic administration on metabolomics and glucose metabolism in CF patients.
    Pediatr Pulmonol. 2022;57:2335-2343.
    PubMed     Abstract available


  330. CHUNG J, Iyengar A, Santry L, Swanson E, et al
    Changes in respiratory management and the impact on bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2022;57:2327-2334.
    PubMed     Abstract available


  331. HAMOUDA S, Hadj Fredj S, Messaoud T, Scotet V, et al
    Up-to-date incidence and initial characteristics of cystic fibrosis in Tunisia.
    Pediatr Pulmonol. 2022;57:2540-2541.
    PubMed    


    September 2022
  332. MARCZAK H, Peradzynska J, Lange J, Boguslawski S, et al
    Pulmonary function in children with persistent tachypnea of infancy.
    Pediatr Pulmonol. 2022 Sep 29. doi: 10.1002/ppul.26162.
    PubMed     Abstract available


  333. YONEDA K, Amari S, Mikami M, Uchida K, et al
    Development of Mortality Prediction Models for Infants with Isolated, Left-Sided Congenital Diaphragmatic Hernia Before and After Birth.
    Pediatr Pulmonol. 2022 Sep 29. doi: 10.1002/ppul.26172.
    PubMed     Abstract available


  334. KASNIYA G, Weinberger B, Cerise J, Pulju M, et al
    Lung Ultrasound Assessment of Pulmonary Edema in Neonates with Chronic Lung Disease Before and After Diuretic Therapy.
    Pediatr Pulmonol. 2022 Sep 29. doi: 10.1002/ppul.26150.
    PubMed     Abstract available


  335. MA HR, Deng BY, Liu J, Jiang P, et al
    Lung Ultrasound to Diagnose Infectious Pneumonia of Newborns: A Prospective Multicenter Study.
    Pediatr Pulmonol. 2022 Sep 28. doi: 10.1002/ppul.26168.
    PubMed     Abstract available


  336. LI L, Liu R, Wang Y, Wang W, et al
    Type II Congenital Pulmonary Airway Malformation with Primary Ciliary Dyskinesia in a 4-year-old Child: A Case Report.
    Pediatr Pulmonol. 2022 Sep 27. doi: 10.1002/ppul.26167.
    PubMed     Abstract available


  337. DANAN C, Tauzin M, Jung C, Durrmeyer X, et al
    Humidity during high-frequency oscillatory ventilation compared to intermittent positive pressure ventilation in extremely preterm neonates: An in vitro and in vivo observational study.
    Pediatr Pulmonol. 2022 Sep 14. doi: 10.1002/ppul.26157.
    PubMed     Abstract available


  338. HARRIS C, Morris S, Lunt A, Peacock J, et al
    Influence of bronchopulmonary dysplasia on lung function in adolescents who were born extremely prematurely.
    Pediatr Pulmonol. 2022 Sep 13. doi: 10.1002/ppul.26151.
    PubMed     Abstract available


  339. JANA T, Vaclav K, Daniela M, Petr K, et al
    Symptomatic preterm infants suffer from lung function deficits, regardless of bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2022 Sep 13. doi: 10.1002/ppul.26144.
    PubMed     Abstract available


  340. GUDMUNDSDOTTIR HK, Hilde K, Bains KES, Fardig M, et al
    Online supplement for the article: Fetal thoracic circumference in mid-pregnancy and infant lung function.
    Pediatr Pulmonol. 2022 Sep 13. doi: 10.1002/ppul.26153.
    PubMed     Abstract available


  341. HAIDER S, Azhar N, Zahid M, Iqbal K, et al
    Comparative effectiveness of Calfactant and Beractant in Neonatal Respiratory Distress Syndrome: A systemic review and meta-analysis.
    Pediatr Pulmonol. 2022 Sep 12. doi: 10.1002/ppul.26149.
    PubMed     Abstract available


  342. DIGGIKAR S, Paul A, Razak A, Chandrasekaran M, et al
    Respiratory Infections in Children Born Preterm in Low and Middle-income countries - A Systematic Review.
    Pediatr Pulmonol. 2022 Sep 7. doi: 10.1002/ppul.26128.
    PubMed     Abstract available


  343. GIACALONE VD, Moncada-Giraldo D, Margaroli C, Brown MR, et al
    Pilot study of inflammatory biomarkers in matched induced sputum and bronchoalveolar lavage of 2-year-olds with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2189-2198.
    PubMed     Abstract available


  344. JANUSKA MN, Langfelder-Schwind E, Berdella MN
    Overcoming health disparities in access to CFTR modulator therapies: One child's journey with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2273-2275.
    PubMed    


  345. SALVATORE D, Cimino G, Troiani P, Bignamini E, et al
    Elexacaftor/tezacaftor/ivacaftor in children aged 6-11 years with cystic fibrosis, at least one F508DEL allele, and advanced lung disease: A 24-week observational study.
    Pediatr Pulmonol. 2022;57:2253-2256.
    PubMed    


  346. STEINDOR M, Wagner CE, Kavvalou A, Bock C, et al
    Indications and outcome of home high-flow nasal therapy in children, a single-center experience.
    Pediatr Pulmonol. 2022;57:2048-2052.
    PubMed     Abstract available


  347. GIARDINA M, Barilla D, Crimi C, Arone A, et al
    Ultrasound-guided placement of long peripheral cannula in children with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2060-2066.
    PubMed     Abstract available


  348. BANWELL E, Collaco JM, Oates GR, Rice JL, et al
    Area deprivation and respiratory morbidities in children with bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2022;57:2053-2059.
    PubMed     Abstract available


    August 2022
  349. SOLIS-GARCIA G, Gonzalez-Pacheco N, Ramos-Navarro C, Vigil-Vazquez S, et al
    Lung recruitment in neonatal high-frequency oscillatory ventilation with volume-guarantee.
    Pediatr Pulmonol. 2022 Aug 22. doi: 10.1002/ppul.26124.
    PubMed     Abstract available


  350. ELDERS BBLJ, Tiddens HAWM, Pijnenburg MWH, Reiss IKM, et al
    Lung structure and function on MRI in preterm born school children with and without BPD: a feasibility study.
    Pediatr Pulmonol. 2022 Aug 18. doi: 10.1002/ppul.26119.
    PubMed     Abstract available


  351. OZAWA Y, Miyake F, Isayama T
    Efficacy and safety of permissive hypercapnia in preterm infants: A systematic review.
    Pediatr Pulmonol. 2022 Aug 9. doi: 10.1002/ppul.26108.
    PubMed     Abstract available


  352. NING J
    A new oxygen therapy support device for infant bronchoscopy?
    Pediatr Pulmonol. 2022 Aug 6. doi: 10.1002/ppul.26105.
    PubMed    


  353. KITAJIMA H, Fujimura M, Takeuchi M, Kawamoto Y, et al
    Intrauterine Ureaplasma is associated with small airway obstruction in extremely preterm infants.
    Pediatr Pulmonol. 2022 Aug 5. doi: 10.1002/ppul.26098.
    PubMed     Abstract available


  354. NASCIMENTO MS, do Prado C, Costa ELV, Alcala GC, et al
    Effect of Flow rate on the end-expiratory lung volume in infants with bronchiolitis using high-flow nasal cannula evaluated through electrical impedance tomography.
    Pediatr Pulmonol. 2022 Aug 5. doi: 10.1002/ppul.26082.
    PubMed     Abstract available


  355. REITER J, Breuer O, Cohen-Cymberknoh M, Forno E, et al
    Sleep in children with cystic fibrosis: More under the covers.
    Pediatr Pulmonol. 2022;57:1944-1951.
    PubMed     Abstract available


    July 2022
  356. ONG JWY, Everitt L, Hiscutt J, Griffiths C, et al
    Characteristics and outcome of infants with bronchopulmonary dysplasia established on long-term ventilation from neonatal intensive care.
    Pediatr Pulmonol. 2022 Jul 19. doi: 10.1002/ppul.26072.
    PubMed     Abstract available


  357. HOUSE M, Klein S, Parham D, Hysinger EB, et al
    Frequent hypoxemia found in infants with bronchopulmonary dysplasia after weaning home oxygen.
    Pediatr Pulmonol. 2022 Jul 13. doi: 10.1002/ppul.26076.
    PubMed     Abstract available


  358. REN CL, Slaven JE, Haas DM, Haneline LS, et al
    Forced Expiratory Flows and Diffusion Capacity in Infants Born from Mothers with Pre-eclampsia.
    Pediatr Pulmonol. 2022 Jul 7. doi: 10.1002/ppul.26064.
    PubMed     Abstract available


  359. BUENDIA JA, Patino DG, Lindarte EF
    Vitamin A supplementation for the prevention of chronic lung disease in premature infants: a cost-utility analysis.
    Pediatr Pulmonol. 2022 Jul 6. doi: 10.1002/ppul.26067.
    PubMed     Abstract available


  360. RODRIGUEZ-FANJUL J, Corsini I, Ortiz CS, Bobillo-Perez S, et al
    Lung ultrasound to evaluate lung recruitment in neonates with respiratory distress (RELUS study).
    Pediatr Pulmonol. 2022 Jul 6. doi: 10.1002/ppul.26066.
    PubMed     Abstract available


  361. GALVIS C, Colmenares A, Cabrales L, Ibata L, et al
    Impact of immunoprophylaxis with palivizumab on respiratory syncytial virus infection in preterm infants less than 35 weeks in Colombian hospitals.
    Pediatr Pulmonol. 2022 Jul 6. doi: 10.1002/ppul.26051.
    PubMed     Abstract available


  362. EGALA A, Hariharan R, Sarangarajan S, Puntambekar A, et al
    An uncommon cause of spontaneous pneumothorax in a febrile infant: Atypical Kawasaki Disease.
    Pediatr Pulmonol. 2022 Jul 5. doi: 10.1002/ppul.26062.
    PubMed     Abstract available


  363. DRISCOLL S, Carroll WD, Nichani S, Fishwick R, et al
    COVID-19 infection and nocardiosis causing the death of an adolescent with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:1823-1825.
    PubMed    


  364. SAVANT AP
    Cystic fibrosis year in review 2021.
    Pediatr Pulmonol. 2022;57:1590-1599.
    PubMed     Abstract available


  365. THAVAMANI A, Umapathi KK, Kutney K, Sferra TJ, et al
    Cystic fibrosis-related liver disease is an independent risk factor for mortality and increased health care resource utilization in hospitalized pediatric patients with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:1717-1725.
    PubMed     Abstract available


  366. MCKINZIE CJ, Kam CW, Parry R, Darby M, et al
    Pharmacist-administered audiology screening for pediatric cystic fibrosis patients exposed to high-dose aminoglycosides: A pilot study.
    Pediatr Pulmonol. 2022;57:1814-1817.
    PubMed     Abstract available


  367. MOLLER R, Nielsen BU, Faurholt-Jepsen D, Katzenstein TL, et al
    Use of inhaled antibiotics among Danish patients with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:1726-1734.
    PubMed     Abstract available


  368. ALLAER L, Lejeune S, Mordacq C, Deschildre A, et al
    Primary ciliary dyskinesia and fungal infections: Two cases of allergic bronchopulmonary aspergillosis in children.
    Pediatr Pulmonol. 2022;57:1809-1813.
    PubMed     Abstract available


  369. COLLACO JM, Tracy MC, Sheils CA, Rice JL, et al
    Insurance coverage and respiratory morbidities in bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2022;57:1735-1743.
    PubMed     Abstract available


  370. BOUZEK DC, Ren CL, Thompson M, Slaven JE, et al
    Evaluating FEV1 decline in diagnosis and management of pulmonary exacerbations in children with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:1709-1716.
    PubMed     Abstract available


  371. MUIRHEAD C, Verzasconi D, Joshi S
    At-home compounding preparation of slow desensitization of elexacaftor/tezacaftor/ivacaftor for delayed hypersensitivity rash.
    Pediatr Pulmonol. 2022;57:1779-1781.
    PubMed     Abstract available


    June 2022
  372. AUER-HACKENBERG L, Stroicz P, Hofstatter E, Brandner J, et al
    Breath-dependent pressure fluctuations in various constant- and variable-flow neonatal CPAP devices.
    Pediatr Pulmonol. 2022 Jun 30. doi: 10.1002/ppul.26050.
    PubMed     Abstract available


  373. RAO P, Charki S, Aradhya AS, Diggikar S, et al
    Prediction score for prolonged hospital stay in Meconium aspiration syndrome: A Multicentric collaborative cohort of South India.
    Pediatr Pulmonol. 2022 Jun 27. doi: 10.1002/ppul.26044.
    PubMed     Abstract available


  374. RUB DM, Sivieri EM, Abbasi S, Sieberlich W, et al
    Comparison of Nasal Intermittent Positive Pressure Ventilation and Bubble CPAP with an In-Line High Frequency Interrupter in a Premature Infant Lung Model.
    Pediatr Pulmonol. 2022 Jun 20. doi: 10.1002/ppul.26039.
    PubMed     Abstract available


  375. KURUMA K, Otomo T, Sakama T, Akiyama K, et al
    Breath sound analyses of infants with respiratory syncytial virus acute bronchiolitis.
    Pediatr Pulmonol. 2022 Jun 7. doi: 10.1002/ppul.26034.
    PubMed     Abstract available


  376. ALESSANDRO P, Annamaria S, Letizia PM, Stefano N, et al
    Early lung ultrasound score to predict non-invasive ventilation needing in neonates from 33 weeks of gestational age: a multi-centric study.
    Pediatr Pulmonol. 2022 Jun 6. doi: 10.1002/ppul.26031.
    PubMed     Abstract available


  377. ENZER KG, Wine TM, Gien J, Somme S, et al
    Posterior tracheopexy for preterm infants with severe bronchopulmonary dysplasia and severe tracheobronchomalacia: A case series.
    Pediatr Pulmonol. 2022 Jun 4. doi: 10.1002/ppul.26029.
    PubMed     Abstract available


  378. ARMERO G, Penela-Sanchez D, Belmonte J, Gomez-Barroso D, et al
    Concentrations of nitrogen compounds are related to severe rhinovirus infection in infants. A time-series analysis from the reference area of a pediatric university hospital in Barcelona.
    Pediatr Pulmonol. 2022 Jun 2. doi: 10.1002/ppul.26021.
    PubMed     Abstract available


  379. ABDELMAWLA M, Seleem W, Farooqui M, Eltayeb A, et al
    Prediction of Weaning Readiness off Nasal CPAP in Preterm Infants Using Point-of-Care Lung Ultrasound.
    Pediatr Pulmonol. 2022 Jun 2. doi: 10.1002/ppul.26014.
    PubMed     Abstract available


  380. MELLOR X, Schindler T, Saab S, Roesch E, et al
    Eosinophilic esophagitis in cystic fibrosis: A case series with long-term follow-up.
    Pediatr Pulmonol. 2022;57:1557-1561.
    PubMed     Abstract available


  381. ISRAELI T, Eisenstadt I, Shoseyov D, Armoni S, et al
    Respiratory physiotherapy in patients with cystic fibrosis and upper limb deep vein thrombosis.
    Pediatr Pulmonol. 2022;57:1552-1554.
    PubMed     Abstract available


  382. XUEREB J, Sammut P, Vella C, Balfour-Lynn IM, et al
    Resolution of lobe collapse in a child with cystic fibrosis with Mycobacterium abscessus using serial intrabronchial rhDNase.
    Pediatr Pulmonol. 2022;57:1549-1551.
    PubMed     Abstract available


  383. YUAN Y, Yang Y, Lei X, Dong W, et al
    Caffeine and bronchopulmonary dysplasia: Clinical benefits and the mechanisms involved.
    Pediatr Pulmonol. 2022;57:1392-1400.
    PubMed     Abstract available


  384. WOJSYK-BANASZAK I, Wieckowska B, Stachowiak Z, Kycler M, et al
    Predictive value of impulse oscillometry and multiple breath washout parameters in pediatric patients with cystic fibrosis pulmonary exacerbation.
    Pediatr Pulmonol. 2022;57:1466-1474.
    PubMed     Abstract available


  385. MARPOLE R, Wilson AC
    Benefits of reviewing pancreatic function in children with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:1537-1539.
    PubMed    


  386. MCKINZIE CJ, Hagood JS, Fiorino EK, Fishman MP, et al
    The role of pharmacy services beyond cystic fibrosis: A case for support in childhood interstitial lung disease.
    Pediatr Pulmonol. 2022;57:1535-1536.
    PubMed    


  387. MELICOFF E, Ruiz FE, Hosek K, Mallory GB, et al
    Cystic fibrosis lung transplant recipients 10 years of age or younger: Predisposing factors for end-stage disease.
    Pediatr Pulmonol. 2022;57:1513-1519.
    PubMed     Abstract available


  388. SUNMAN B, Emiralioglu N, Hazirolan G, Sener B, et al
    Effectiveness of different eradication treatment protocols for new-onset Pseudomonas aeruginosa in children with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:1456-1465.
    PubMed     Abstract available



  389. V. YOUNG INVESTIGATOR'S ORAL COMMUNICATIONS.
    Pediatr Pulmonol. 2022;57 Suppl 2:S89-S93.
    PubMed    


    May 2022
  390. COUSINS M, Hart K, Williams EM, Kotecha S, et al
    Impaired exercise outcomes with significant bronchodilator responsiveness in children with prematurity-associated obstructive lung disease.
    Pediatr Pulmonol. 2022 May 30. doi: 10.1002/ppul.26019.
    PubMed     Abstract available


  391. CORSINI I, Parri N, Ficial B, Ciarcia M, et al
    Lung ultrasound in Italian Neonatal Intensive Care Units: a national survey.
    Pediatr Pulmonol. 2022 May 30. doi: 10.1002/ppul.26025.
    PubMed     Abstract available


  392. EL-SHEIKH M, Elmahdy H, Nassar M, Fouda M, et al
    Role of Soluble Triggering Receptors Expressed on Myeloid Cells -1 and 25-hydroxy Vitamin D as Early Diagnostic Markers of Neonatal Ventilator-Associated Pneumonia: A Prospective Cohort Study.
    Pediatr Pulmonol. 2022 May 27. doi: 10.1002/ppul.26016.
    PubMed     Abstract available


  393. VERD S, Morey R, Ginovart G, Moliner E, et al
    Due emphasis on the role of human milk feeding to prevent neonatal respiratory morbidity.
    Pediatr Pulmonol. 2022 May 26. doi: 10.1002/ppul.26017.
    PubMed     Abstract available


  394. KUGELMAN A
    *Neonatal Pulmonology: "Year in Review" for the Pediatric Pulmonologist.
    Pediatr Pulmonol. 2022 May 20. doi: 10.1002/ppul.25960.
    PubMed     Abstract available


  395. SOONG WJ, Tsao PC, Yang CF, Sung YH, et al
    Early detection of laryngeal cleft in infants by novel technique of flexible endoscopy with sustained pharyngeal inflation.
    Pediatr Pulmonol. 2022 May 20. doi: 10.1002/ppul.25988.
    PubMed     Abstract available


  396. MIKHAEL M, Cleary JP, Zaniletti I, Truog WE, et al
    Chronic Lung Disease in Full-Term Infants: Characteristics and Neonatal Intensive Care Outcomes in Infants Referred to Children's Hospitals.
    Pediatr Pulmonol. 2022 May 16. doi: 10.1002/ppul.25983.
    PubMed     Abstract available


  397. LUCIA L, Correani A, Pasqualini M, Antognoli L, et al
    Respiratory distress syndrome in preterm infants of less than 32 weeks: What difference does giving 100 or 200 mg/kg of exogenous surfactant make?
    Pediatr Pulmonol. 2022 May 16. doi: 10.1002/ppul.25979.
    PubMed     Abstract available


  398. MONTERO-GATO J, Rodeno-Fernandez L, Serna-Guerediaga I, Aguirre-Unceta-Barrenechea A, et al
    Response to the letter entitled: "Ultrasound of pneumothorax in neonates: Diagnostic value of the anterior transverse plane and of mirrored ribs; Methodological issues".
    Pediatr Pulmonol. 2022 May 16. doi: 10.1002/ppul.25976.
    PubMed     Abstract available


  399. SABOUR S
    Ultrasound of pneumothorax in neonates: Diagnostic value of the anterior transverse plane and of mirrored ribs; Methodological issues.
    Pediatr Pulmonol. 2022 May 16. doi: 10.1002/ppul.25977.
    PubMed     Abstract available


  400. WELBEL RZ, Rand CM, Zhou A, Fadl-Alla A, et al
    Neurocognitive Monitoring in Congenital Central Hypoventilation Syndrome with the NIH Toolbox.
    Pediatr Pulmonol. 2022 May 16. doi: 10.1002/ppul.25973.
    PubMed     Abstract available


  401. LIM AM, Tan PL, Visruthan NK, Fong N, et al
    HIDEA Syndrome: A rare cause of congenital hypoventilation in a premature infant.
    Pediatr Pulmonol. 2022 May 11. doi: 10.1002/ppul.25966.
    PubMed     Abstract available


  402. GOUSSARD P, Merven M, Parker N, Gie A, et al
    Foreign body aspiration in two young infants: The devil in the carpet.
    Pediatr Pulmonol. 2022 May 11. doi: 10.1002/ppul.25965.
    PubMed     Abstract available


  403. ARIFF S, Ali KQ, Tessaro MO, Ansari U, et al
    Diagnostic Accuracy of Point-of-Care Ultrasound Compared to Standard-of-Care Methods for Endotracheal Tube Placement in Neonates.
    Pediatr Pulmonol. 2022 May 2. doi: 10.1002/ppul.25955.
    PubMed     Abstract available


  404. FRAUCHIGER BS, Oestreich MA, Wyler F, Monney N, et al
    Do clinimetric properties of LCI change after correction of signal processing?
    Pediatr Pulmonol. 2022;57:1180-1187.
    PubMed     Abstract available


  405. KENIS-COSKUN O, Aksoy AN, Kumas EN, Yilmaz A, et al
    The effect of telerehabilitation on quality of life, anxiety, and depression in children with cystic fibrosis and caregivers: A single-blind randomized trial.
    Pediatr Pulmonol. 2022;57:1262-1271.
    PubMed     Abstract available


  406. KRAMER-GOLINKOFF E, Camacho A, Kramer L, Taylor-Cousar JL, et al
    A survey: Understanding the health and perspectives of people with CF not benefiting from CFTR modulators.
    Pediatr Pulmonol. 2022;57:1253-1261.
    PubMed     Abstract available


  407. LIM JT, Ly NP, Willen SM, Iwanaga K, et al
    Food insecurity and mental health during the COVID-19 pandemic in cystic fibrosis households.
    Pediatr Pulmonol. 2022;57:1238-1244.
    PubMed     Abstract available


  408. ASFUROGLU P, Sismanlar Eyuboglu T, Aslan AT, Gursoy TR, et al
    The success of the Cystic Fibrosis Registry of Turkey for improvement of patient care.
    Pediatr Pulmonol. 2022;57:1245-1252.
    PubMed     Abstract available


    April 2022
  409. GHOSH RN, Guglani L, Westbrook AL, Mao CY, et al
    Impaired Ventilation during Six-Minute Walk Test in Congenital Central Hypoventilation Syndrome.
    Pediatr Pulmonol. 2022 Apr 22. doi: 10.1002/ppul.25940.
    PubMed     Abstract available


  410. IZQUIERDO ME, Marion CR, Moore WC, Raraigh K, et al
    DNA Sequencing Analysis of Cystic Fibrosis Transmembrane Regulator Gene Identifies Cystic Fibrosis-Associated Variants in the Severe Asthma Research Program.
    Pediatr Pulmonol. 2022 Apr 21. doi: 10.1002/ppul.25939.
    PubMed     Abstract available


  411. ZAITSU M, Matsuo M
    Transient low IgG4 levels cause recurrent wheezing requiring multiple hospitalizations in infancy.
    Pediatr Pulmonol. 2022 Apr 18. doi: 10.1002/ppul.25927.
    PubMed     Abstract available


  412. FELDMAN K, Nitkin CR, Cuna A, Oschman A, et al
    Corticosteroid Response Predicts Bronchopulmonary Dysplasia Status at 36 Weeks in Preterm Infants Treated with Dexamethasone: A Pilot Study.
    Pediatr Pulmonol. 2022 Apr 17. doi: 10.1002/ppul.25928.
    PubMed     Abstract available


  413. KOUCKY V, Komarek A, Pohunek P
    Repeatability of lung clearance index in infants with cystic fibrosis and recurrent wheeze.
    Pediatr Pulmonol. 2022 Apr 13. doi: 10.1002/ppul.25921.
    PubMed     Abstract available


  414. MATERA L, Nenna R, Frassanito A, Petrarca L, et al
    Low lymphocyte count: a clinical severity marker in infants with bronchiolitis.
    Pediatr Pulmonol. 2022 Apr 11. doi: 10.1002/ppul.25919.
    PubMed     Abstract available


  415. BISQUERA A, MBChB CH, Lunt A, Zivanovic S, et al
    Longitudinal changes in lung function in very prematurely born young people receiving high frequency oscillation or conventional ventilation from birth.
    Pediatr Pulmonol. 2022 Apr 6. doi: 10.1002/ppul.25918.
    PubMed     Abstract available


  416. CALISKAN AB, Horani A, Manion M, Brody SL, et al
    Variations in infection control practices suggest a need for guidelines in primary ciliary dyskinesia patient care.
    Pediatr Pulmonol. 2022;57:1072-1075.
    PubMed     Abstract available


  417. MANZAR S
    Successful Extubation in Preterm Infants.
    Pediatr Pulmonol. 2022 Apr 1. doi: 10.1002/ppul.25908.
    PubMed     Abstract available


  418. KENNEDY C, Greenberg I, Perez GF, Chaney H, et al
    Measuring the impact of an empiric antibiotic algorithm for pulmonary exacerbation in children and young adults with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:965-975.
    PubMed     Abstract available


  419. MANIKA K, Hatziagorou E, Kotoulas SC, Kyrvasili SS, et al
    Adherence to inhaled therapies over 4 years in people with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:956-964.
    PubMed     Abstract available


  420. LAI HJ, Chin LH, Murali S, Bach T, et al
    Vitamins A, D, E status as related to supplementation and lung disease markers in young children with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:935-944.
    PubMed     Abstract available


  421. IMBURGIA TA, Engdahl SR, Pettit RS
    Evaluation of the safety of cefepime prolonged infusions in pediatric patients with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:919-925.
    PubMed     Abstract available


  422. SHAKKOTTAI A, Irani S, Nasr SZ, O'Brien LM, et al
    Risk factors for obstructive sleep apnea in cystic fibrosis.
    Pediatr Pulmonol. 2022;57:926-934.
    PubMed     Abstract available


  423. SAKON C, Alicea LA, Patacca H, Brown CD, et al
    Opportunity for pharmacogenomic testing in patients with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:903-907.
    PubMed     Abstract available


  424. ZAMPOLI M, Kassanjee R, Verstraete J, Westwood A, et al
    Trends in cystic fibrosis survival over 40 years in South Africa: An observational cohort study.
    Pediatr Pulmonol. 2022;57:908-918.
    PubMed     Abstract available


    March 2022
  425. GUPTA VS, Wilson C, Popp EC, Zhaorigetu S, et al
    Neonatal rodent ventilation and clinical correlation in congenital diaphragmatic hernia.
    Pediatr Pulmonol. 2022 Mar 30. doi: 10.1002/ppul.25911.
    PubMed     Abstract available


  426. SCHOBER M, Bohnhorst B, Annon-Eberharter N, Wald M, et al
    Dead space washout by intentional leakage flow during conventional ventilation of premature infants - an experimental study.
    Pediatr Pulmonol. 2022 Mar 30. doi: 10.1002/ppul.25906.
    PubMed     Abstract available


  427. RALLIS D, Baltogianni M, Dermitzaki N, Balomenou F, et al
    Clara Cell Protein Expression Amongst Infants with Respiratory Distress Syndrome.
    Pediatr Pulmonol. 2022 Mar 18. doi: 10.1002/ppul.25897.
    PubMed     Abstract available


  428. ARAKI R, Tomotaki S, Akita M, Motokura K, et al
    Effect of doxapram on the electrical activity of the diaphragm waveform pattern of preterm infants.
    Pediatr Pulmonol. 2022 Mar 11. doi: 10.1002/ppul.25889.
    PubMed     Abstract available


  429. PIATEK K, Lehtonen L, Parikka V, Setanen S, et al
    Implementation of neurally adjusted ventilatory assist and high flow nasal cannula in very preterm infants in a tertiary level NICU.
    Pediatr Pulmonol. 2022 Mar 3. doi: 10.1002/ppul.25879.
    PubMed     Abstract available


  430. GOUSSARD P, Schubert P, Parker N, Myburgh C, et al
    GOUSSARD et al."To the Editor"Fatal SARS-CoV-2 Omicron variant in a young infant: Autopsy findings.
    Pediatr Pulmonol. 2022 Mar 3. doi: 10.1002/ppul.25881.
    PubMed    


  431. SUNMAN B, Emiralioglu N, Hazirolan G, Ademhan Tural D, et al
    Impact of Achromobacter spp. isolation on clinical outcomes in children with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:658-666.
    PubMed     Abstract available


  432. WRIGHT BA, Ketchen NK, Rasmussen LN, Bartels AR, et al
    Impact of elexacaftor/tezacaftor/ivacaftor on vitamin D absorption in cystic fibrosis patients.
    Pediatr Pulmonol. 2022;57:655-657.
    PubMed     Abstract available


  433. SATHE M, Paul GR, Faro A
    A step back in time: The basics of CF care still matter!
    Pediatr Pulmonol. 2022;57:597-599.
    PubMed    


  434. KAUR H, Pandey S, Jat KR, Lodha R, et al
    Predictors of mortality in children with cystic fibrosis in India.
    Pediatr Pulmonol. 2022;57:648-654.
    PubMed     Abstract available


    February 2022
  435. CORSINI I, Ciarcia M, Ficial B, Capasso L, et al
    LUNG ULTRASOUND SCORES IN NEONATAL CLINICAL PRACTICE: A NARRATIVE REVIEW OF THE LITERATURE.
    Pediatr Pulmonol. 2022 Feb 28. doi: 10.1002/ppul.25875.
    PubMed     Abstract available


  436. KORPPI M
    Eosinophil activity in infancy predicts the outcome of infant bronchiolitis.
    Pediatr Pulmonol. 2022 Feb 27. doi: 10.1002/ppul.25871.
    PubMed     Abstract available


  437. SCHNAPPER M, Dalal I, Mandelberg A, Sternfeld AR, et al
    Bronchoscopy in the management of children from developing countries undergoing congenital heart surgery.
    Pediatr Pulmonol. 2022 Feb 24. doi: 10.1002/ppul.25869.
    PubMed     Abstract available


  438. BUCK CO, Taylor SN
    Commentary on "Compatibility of rapid enteral feeding advances and noninvasive ventilation in preterm infants - an observational study".
    Pediatr Pulmonol. 2022 Feb 21. doi: 10.1002/ppul.25867.
    PubMed     Abstract available


  439. BEHNKE J, Estreich V, Oehmke F, Zimmer KP, et al
    Compatibility of rapid enteral feeding advances and non-invasive ventilation in preterm infants - an observational study.
    Pediatr Pulmonol. 2022 Feb 21. doi: 10.1002/ppul.25868.
    PubMed     Abstract available


  440. XU KK, Wegner DJ, Geurts LC, Heins HB, et al
    Biologic Characterization of ABCA3 Variants in Lung Tissue from Infants and Children with ABCA3 Deficiency.
    Pediatr Pulmonol. 2022 Feb 15. doi: 10.1002/ppul.25862.
    PubMed     Abstract available


  441. RAGAN H, Autry E, Bomersback T, Hewlett J, et al
    The use of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis postliver transplant: A case series.
    Pediatr Pulmonol. 2022;57:411-417.
    PubMed     Abstract available


  442. ANTOS NJ, Savant AP
    Cystic fibrosis year in review 2020: Section 2 pulmonary disease, infections, and inflammation.
    Pediatr Pulmonol. 2022;57:347-360.
    PubMed     Abstract available


  443. MCBENNETT KA, Davis PB, Konstan MW
    Increasing life expectancy in cystic fibrosis: Advances and challenges.
    Pediatr Pulmonol. 2022;57 Suppl 1:S5-S12.
    PubMed     Abstract available


  444. JOBANPUTRA A, Jagpal S, Marulanda P, Ramagopal M, et al
    An overview of noninvasive ventilation in cystic fibrosis.
    Pediatr Pulmonol. 2022;57 Suppl 1:S101-S112.
    PubMed     Abstract available


  445. GABEL ME, Fox CK, Grimes RA, Lowman JD, et al
    Overweight and cystic fibrosis: An unexpected challenge.
    Pediatr Pulmonol. 2022;57 Suppl 1:S40-S49.
    PubMed     Abstract available


  446. SALA MA, Vitale KM, Prickett M
    Looking toward the future: Approaching care of the aging CF patient.
    Pediatr Pulmonol. 2022;57 Suppl 1:S113-S117.
    PubMed     Abstract available


  447. ROWBOTHAM NJ, Daniels TE
    Airway clearance and exercise for people with cystic fibrosis: Balancing longevity with life.
    Pediatr Pulmonol. 2022;57 Suppl 1:S50-S59.
    PubMed     Abstract available


  448. WRIGHT M, Wright T
    Health disparity in CF: Perspectives from a lived experience.
    Pediatr Pulmonol. 2022;57 Suppl 1:S13-S16.
    PubMed     Abstract available


  449. WEST NE, Kazmerski TM, Taylor-Cousar JL, Tangpricha V, et al
    Optimizing sexual and reproductive health across the lifespan in people with cystic fibrosis.
    Pediatr Pulmonol. 2022;57 Suppl 1:S89-S100.
    PubMed     Abstract available


  450. LAHIRI T, Sullivan JS
    Recent advances in the early treatment of cystic fibrosis: Bridging the gap to highly effective modulator therapy.
    Pediatr Pulmonol. 2022;57 Suppl 1:S60-S74.
    PubMed     Abstract available


  451. KAZMERSKI TM, West NE, Jain R, Uluer A, et al
    Family-building and parenting considerations for people with cystic fibrosis.
    Pediatr Pulmonol. 2022;57 Suppl 1:S75-S88.
    PubMed     Abstract available


  452. GRANT JJ, McDade EJ, Zobell JT, Young DC, et al
    The indispensable role of pharmacy services and medication therapy management in cystic fibrosis.
    Pediatr Pulmonol. 2022;57 Suppl 1:S17-S39.
    PubMed     Abstract available


    January 2022
  453. SOLA-MARTINEZ RA, Sanchez-Solis M, Lozano-Terol G, Gallego-Jara J, et al
    Relationship between lung function and exhaled volatile organic compounds in healthy infants.
    Pediatr Pulmonol. 2022 Jan 29. doi: 10.1002/ppul.25849.
    PubMed     Abstract available


  454. BEQIRAJ-ZEQIRAJ Q, Thaci Q, Sahiti F, Kovac Z, et al
    Rho-kinase inhibitors protect against neonatal hyperoxia-induced airway hyperreactivity in a rat pup model: role of prostaglandin F2alpha.
    Pediatr Pulmonol. 2022 Jan 28. doi: 10.1002/ppul.25848.
    PubMed     Abstract available


  455. GEORGE A, Ortenberg R, Pinto S
    A case of Recurrent Pneumothoraces in a Newborn.
    Pediatr Pulmonol. 2022 Jan 25. doi: 10.1002/ppul.25844.
    PubMed     Abstract available


  456. IWAI M, Yoshimatsu H, Naramura T, Imamura H, et al
    Procalcitonin is associated with postnatal respiratory condition severity in preterm neonate: Conclusion: The serum PCT levels in preterm neonates were associated with postnatal respiratory condition severity.
    Pediatr Pulmonol. 2022 Jan 22. doi: 10.1002/ppul.25846.
    PubMed     Abstract available


  457. DE QUEIROZ ANDRADE E, Bayfield KJ, Blaxland A, Wong A, et al
    Exposure to 4% SF6 during multiple breath washout affects subsequent infant tidal breathing analysis.
    Pediatr Pulmonol. 2022 Jan 20. doi: 10.1002/ppul.25820.
    PubMed    


  458. ELGENDY MM, Aly H, Adisa A, Mohamed MA, et al
    Disparities in tracheostomies and gastrostomy tubes in infants at the edge of viability.
    Pediatr Pulmonol. 2022 Jan 20. doi: 10.1002/ppul.25841.
    PubMed     Abstract available


  459. RUSCONI F, Lombardi E, Spada E, Brescianini S, et al
    Lung function at school age in infants with lower respiratory tract infections with and without wheezing: a birth cohort study.
    Pediatr Pulmonol. 2022 Jan 19. doi: 10.1002/ppul.25835.
    PubMed     Abstract available


  460. LI J, Zhang J, Hao Q, Chen H, et al
    Erythropoietin for preventing bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis.
    Pediatr Pulmonol. 2022 Jan 18. doi: 10.1002/ppul.25837.
    PubMed     Abstract available


  461. BEYDON N, Lucas JS
    Letter to the Editor on "Feasibility of nasal NO screening in healthy newborns".
    Pediatr Pulmonol. 2022 Jan 17. doi: 10.1002/ppul.25784.
    PubMed    


  462. MOHSEN N, Nasef N, Elkhouli M, Ghanem M, et al
    Predictors of Successful Trial off Continuous Positive Airway Pressure and High Flow Nasal Cannula in Preterm Infants < 30 weeks| gestation: A Retrospective Study.
    Pediatr Pulmonol. 2022 Jan 15. doi: 10.1002/ppul.25827.
    PubMed     Abstract available


  463. SANDVIK RM, Gustafsson PM, Lindblad A, Buchvald F, et al
    Contemporary N2 and SF6 multiple breath washout in infants and toddlers with cystic fibrosis.
    Pediatr Pulmonol. 2022 Jan 13. doi: 10.1002/ppul.25830.
    PubMed     Abstract available


  464. GATO JM, Fernandez LR, Guerediaga IS, Unceta-Barrenechea AA, et al
    Ultrasound of Pneumothorax in Neonates: Diagnostic Value of the Anterior Transverse Plane and of Mirrored Ribs.
    Pediatr Pulmonol. 2022 Jan 13. doi: 10.1002/ppul.25829.
    PubMed     Abstract available


  465. ADAIKALAM SA, Higano NS, Hysinger EB, Bates AJ, et al
    Tracheostomy prediction model in neonatal bronchopulmonary dysplasia via lung and airway MRI.
    Pediatr Pulmonol. 2022 Jan 13. doi: 10.1002/ppul.25826.
    PubMed     Abstract available


  466. WONG CK, Harris L, Hicks M, Majaesic C, et al
    Tracheostomies in Term and Preterm Infants: A Single Center Canadian Retrospective Cohort.
    Pediatr Pulmonol. 2022 Jan 11. doi: 10.1002/ppul.25823.
    PubMed     Abstract available


  467. DANI C, Ciarcia M, Miselli F, Luzzati M, et al
    MEASUREMENT OF LUNG OXYGENATION BY NEAR INFRARED SPECTROSCOPY IN PRETERM INFANTS WITH RESPIRATORY DISTRESS SYNDROME: A PROOF OF CONCEPT STUDY.
    Pediatr Pulmonol. 2022 Jan 11. doi: 10.1002/ppul.25824.
    PubMed     Abstract available


  468. ROSENFELD N, Mandelberg A, Dalal I, Tasher D, et al
    The Impact of the COVID-19 Pandemic on respiratory morbidity during infancy: A birth-cohort study.
    Pediatr Pulmonol. 2022 Jan 11. doi: 10.1002/ppul.25822.
    PubMed     Abstract available


  469. O'CONNOR K, Hurst C, Llewellyn S, Davies M, et al
    Factors associated with successful extubation following the first course of systemic dexamethasone in ventilator dependent preterm infants with or at risk of developing bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2022 Jan 7. doi: 10.1002/ppul.25821.
    PubMed     Abstract available


  470. GENTLE SJ, Sant'Anna G, Carlo WA
    Using Dexamethasone Wisely in Invasively Ventilated Preterm Infants.
    Pediatr Pulmonol. 2022 Jan 7. doi: 10.1002/ppul.25819.
    PubMed     Abstract available


  471. GE H, Qiao Y, Ge J, Li J, et al
    Effects of early Vitamin D supplementation on the prevention of bronchopulmonary dysplasia in preterm infants.
    Pediatr Pulmonol. 2022 Jan 6. doi: 10.1002/ppul.25813.
    PubMed     Abstract available


  472. KIELT MJ, Murphy A, Smathers J, Bates M, et al
    In-hospital respiratory viral infections for patients with established BPD in the SARS-CoV-2 era.
    Pediatr Pulmonol. 2022;57:200-208.
    PubMed     Abstract available


  473. FETTES E, Riley M, Brotherston S, Doughty C, et al
    "You're on mute!" Does pediatric CF home spirometry require physiologist supervision?
    Pediatr Pulmonol. 2022;57:278-284.
    PubMed     Abstract available


  474. ADEMHAN TURAL D, Yalcin E, Emiralioglu N, Ozsezen B, et al
    Comparison of inhaled mannitol/dornase alfa combination and daily dornase alfa alone in children with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:142-151.
    PubMed     Abstract available


  475. POORE TS, Meier M, Towler E, Martiniano SL, et al
    Clinical characteristics of people with cystic fibrosis and frequent fungal infection.
    Pediatr Pulmonol. 2022;57:152-161.
    PubMed     Abstract available


  476. MARIANI A, Gambazza S, Carta F, Ambrogi F, et al
    Prevalence and factors associated with urinary incontinence in females with cystic fibrosis: An Italian single-center cross-sectional analysis.
    Pediatr Pulmonol. 2022;57:132-141.
    PubMed     Abstract available


  477. SEBLANI MD, McColley SA, Gong S, Bass LM, et al
    A rare case of pancytopenia in a child with cystic fibrosis: Can copper cure it all?
    Pediatr Pulmonol. 2022;57:317-319.
    PubMed    


  478. DEVI U, Roberts KD, Pandita A
    A systematic review of surfactant delivery via laryngeal mask airway, pharyngeal instillation, and aerosolization: Methods, limitations, and outcomes.
    Pediatr Pulmonol. 2022;57:9-19.
    PubMed     Abstract available


    December 2021
  479. RIGOTTI C, Zannin E, Abdelfattah AS, Ventura ML, et al
    Assessment of bronchodilator response by forced oscillation technique in a preterm infant with evolving bronchopulmonary dysplasia: a case report.
    Pediatr Pulmonol. 2021 Dec 30. doi: 10.1002/ppul.25812.
    PubMed     Abstract available


  480. SZABO H, Baraldi E, Colin AA
    Corticosteroids in the prevention and treatment of infants with bronchopulmonary dysplasia: Part II. Inhaled corticosteroids alone or in combination with surfactants.
    Pediatr Pulmonol. 2021 Dec 29. doi: 10.1002/ppul.25808.
    PubMed     Abstract available


  481. SZABO H, Baraldi E, Colin AA
    Corticosteroids in the prevention and treatment of infants with bronchopulmonary dysplasia: Part I. Systemic corticosteroids.
    Pediatr Pulmonol. 2021 Dec 29. doi: 10.1002/ppul.25805.
    PubMed     Abstract available


  482. LANGFELDER-SCHWIND E, Raraigh KS, Parad RB
    Genetic counseling access for parents of newborns who screen positive for cystic fibrosis: consensus guidelines.
    Pediatr Pulmonol. 2021 Dec 29. doi: 10.1002/ppul.25806.
    PubMed     Abstract available


  483. GUPTA N, Chattopadhyay A, Nyayadhish RK, Saikia D, et al
    Necrotising MRSA pneumonia with mycotic pulmonary artery pseudo - aneurysm in an infant.
    Pediatr Pulmonol. 2021 Dec 22. doi: 10.1002/ppul.25800.
    PubMed    


  484. PELES G, Paz-Levy D, Wainstock T, Goldbart A, et al
    Pediatric respiratory hospitalizations in small for gestational age neonates born at term.
    Pediatr Pulmonol. 2021 Dec 20. doi: 10.1002/ppul.25797.
    PubMed     Abstract available


  485. BALAZS G, Balajthy A, Riszter M, Kovacs T, et al
    Incidence, predictors of success and outcome of LISA in very preterm infants.
    Pediatr Pulmonol. 2021 Dec 20. doi: 10.1002/ppul.25798.
    PubMed     Abstract available


  486. FRASSANITO A, Nenna R, Arima S, Petrarca L, et al
    Modifiable environmental factors predispose term infants to bronchiolitis but bronchiolitis itself predisposes to respiratory sequelae.
    Pediatr Pulmonol. 2021 Dec 17. doi: 10.1002/ppul.25794.
    PubMed     Abstract available


  487. RAMIREZ-SUAREZ KI, Barrera CA, Otero HJ, Biko DM, et al
    Pilot study for comparative assessment of dual-energy computed tomography and single-photon emission computed tomography V/Q scanning for lung perfusion evaluation in infants.
    Pediatr Pulmonol. 2021 Dec 16. doi: 10.1002/ppul.25788.
    PubMed     Abstract available


  488. XU W, Gao Y, Li W, Chen Z, et al
    A National descriptive epidemiologic analysis on congenital pulmonary airway malformation in China, 2010-2019.
    Pediatr Pulmonol. 2021 Dec 9. doi: 10.1002/ppul.25785.
    PubMed     Abstract available


  489. VIRGIN FW, Thurm C, Sanders DB, Freeman AJ, et al
    Prevalence, variability, and predictors of sinus surgery in pediatric patients with cystic fibrosis.
    Pediatr Pulmonol. 2021;56:4029-4038.
    PubMed     Abstract available


  490. MASSIE J
    Miracles in my time: Reflections of a pediatric respiratory physician.
    Pediatr Pulmonol. 2021;56:3586-3591.
    PubMed     Abstract available


  491. ALIBAKHSHI R, Mohammadi A, Khamooshian S, Kazeminia M, et al
    CFTR gene mutation spectrum among 735 Iranian patients with cystic fibrosis: A comprehensive systematic review.
    Pediatr Pulmonol. 2021;56:3644-3656.
    PubMed     Abstract available


  492. ANDERSON A, McCoy L, Pettit RS, Wright BA, et al
    Early insurance coverage of elexacaftor/tezacaftor/ivacaftor for cystic fibrosis.
    Pediatr Pulmonol. 2021;56:4053-4054.
    PubMed    


  493. WILSON LM, Ellis MJ, Lane RL, Wilson JW, et al
    Development of the A-STEP: A new incremental maximal exercise capacity step test in cystic fibrosis.
    Pediatr Pulmonol. 2021;56:3777-3784.
    PubMed     Abstract available


  494. BOKOV P, Gerardin M, Le Clainche L, Houdouin V, et al
    Impulse oscillometry indices to detect an abnormal lung clearance index in childhood cystic fibrosis.
    Pediatr Pulmonol. 2021;56:3752-3757.
    PubMed     Abstract available


  495. MURSALOGLU HH, Akin C, Yilmaz Yegit C, Ergenekon AP, et al
    Comparison of intravenous and non-intravenous antibiotic regimens in eradication of P. aeruginosa and MRSA in cystic fibrosis.
    Pediatr Pulmonol. 2021;56:3745-3751.
    PubMed     Abstract available


  496. MCCASHNEY A, Robinson P
    Structural lung disease following allergic bronchopulmonary aspergillosis complicating pediatric cystic fibrosis.
    Pediatr Pulmonol. 2021;56:3737-3744.
    PubMed     Abstract available


  497. GOETZ DM, Savant AP
    Review of CFTR modulators 2020.
    Pediatr Pulmonol. 2021;56:3595-3606.
    PubMed     Abstract available


  498. OCHS MA, Dillman NO, Caverly LJ, Chaffee VD, et al
    Aminoglycoside dosing and monitoring for Pseudomonas aeruginosa during acute pulmonary exacerbations in cystic fibrosis.
    Pediatr Pulmonol. 2021;56:3634-3643.
    PubMed     Abstract available


    November 2021
  499. NAYIR BUYUKSAHIN H, Emiralioglu N, Ozsezen B, Ademhan Tural D, et al
    Cystic Fibrosis Newborn Screening: Five-year Experience from a Tertiary Care Center.
    Pediatr Pulmonol. 2021 Nov 29. doi: 10.1002/ppul.25778.
    PubMed     Abstract available


  500. PELUSO AM, Othman HF, Karnati S, Sammour I, et al
    Epidemiologic evaluation of inhaled nitric oxide use among neonates with gestational age less than 35 weeks.
    Pediatr Pulmonol. 2021 Nov 29. doi: 10.1002/ppul.25775.
    PubMed     Abstract available


  501. WHITE H, Sobelman C, Kremer T, Lee A, et al
    Does Recorded Oximetry Utilizing a Consensus Based Algorithm Compare to Polysomnography in Discontinuing Home Oxygen Therapy in Premature Infants.
    Pediatr Pulmonol. 2021 Nov 23. doi: 10.1002/ppul.25770.
    PubMed     Abstract available


  502. BUENDIA JA, Ramirez C, Benjumea-Bedoya D
    Bronchopulmonary dysplasia: incidence and severity in premature infants born at high altitude.
    Pediatr Pulmonol. 2021 Nov 18. doi: 10.1002/ppul.25763.
    PubMed     Abstract available


  503. NOBILE S, Marchionni P, Meneghin F, Salvatore S, et al
    Esophageal impedance baseline in infants with bronchopulmonary dysplasia: a pilot study.
    Pediatr Pulmonol. 2021 Nov 15. doi: 10.1002/ppul.25758.
    PubMed     Abstract available


  504. TANG W, Chen S, Shi D, Ai T, et al
    Effectiveness and safety of early combined utilization of budesonide and surfactant by airway for Bronchopulmonary dysplasia prevention in premature infants with RDS: A meta-analysis.
    Pediatr Pulmonol. 2021 Nov 15. doi: 10.1002/ppul.25759.
    PubMed     Abstract available


  505. VOYNOW JA, Feng R, Ren CL, Dylag AM, et al
    Pulmonary function tests in extremely low gestational age infants at one year of age.
    Pediatr Pulmonol. 2021 Nov 14. doi: 10.1002/ppul.25757.
    PubMed     Abstract available


  506. CUEVAS GUAMAN M, Dahm PH, Welty SE
    The challenge of accurately describing the epidemiology of bronchopulmonary dysplasia (BPD) based on the various current definitions of BPD.
    Pediatr Pulmonol. 2021;56:3527-3532.
    PubMed     Abstract available


  507. HYSINGER EB
    Central airway issues in bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2021;56:3518-3526.
    PubMed     Abstract available


  508. YALLAPRAGADA SG, Savani RC, Goss KN
    Cardiovascular impact and sequelae of bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2021;56:3453-3463.
    PubMed     Abstract available


  509. COLLACO JM, McGrath-Morrow SA
    Bronchopulmonary dysplasia as a determinant of respiratory outcomes in adult life.
    Pediatr Pulmonol. 2021;56:3464-3471.
    PubMed     Abstract available


  510. BAKER CD
    Chronic respiratory failure in bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2021;56:3490-3498.
    PubMed     Abstract available


  511. ALLEN J, Panitch H
    Bronchopulmonary dysplasia-A historical perspective.
    Pediatr Pulmonol. 2021;56:3478-3489.
    PubMed     Abstract available


    October 2021
  512. BAKHLE A, Sreekumar K, Baracho B, Sardessai S, et al
    Cavitary lung lesions in a neonate: Potential manifestation of COVID-19 related multisystem inflammatory syndrome.
    Pediatr Pulmonol. 2021 Oct 29. doi: 10.1002/ppul.25732.
    PubMed     Abstract available


  513. LI J, Xu H
    Comparisons of two definitions of Bronchopulmonary Dysplasia for the premature infants.
    Pediatr Pulmonol. 2021 Oct 23. doi: 10.1002/ppul.25739.
    PubMed     Abstract available


  514. XU S, Yang C, Gan Y, Jiang G, et al
    A 4-day-old newborn with an isolated sternal cleft: A rare case and literature review.
    Pediatr Pulmonol. 2021 Oct 12. doi: 10.1002/ppul.25677.
    PubMed     Abstract available


  515. LEWIS L, Sinha I, Losty PD
    Respiratory Syncytial Virus Bronchiolitis in Congenital Diaphragmatic Hernia: A systematic review of prevalence rates and Palivizumab prophylaxis.
    Pediatr Pulmonol. 2021 Oct 6. doi: 10.1002/ppul.25717.
    PubMed     Abstract available


  516. DELL'ORTO V, Nobile S, Correani A, Marchionni P, et al
    Early nasal continuous positive airway pressure failure prediction in preterm infants less than 32 weeks gestational age suffering from respiratory distress syndrome.
    Pediatr Pulmonol. 2021 Oct 5. doi: 10.1002/ppul.25678.
    PubMed     Abstract available


  517. WANG Y, Hong X, Yao TC, Tsai HJ, et al
    Interaction of maternal asthma history and plasma folate levels on child asthma risk in the Boston Birth Cohort.
    Pediatr Pulmonol. 2021 Oct 4. doi: 10.1002/ppul.25680.
    PubMed     Abstract available


  518. ANDERSON E, Gregoski MJ, Gehle D, Head WT, et al
    Severity of respiratory disease is correlated with time of first oral feeding and need for a gastrostomy tube at discharge in premature infants born at <30 weeks of gestation.
    Pediatr Pulmonol. 2021 Oct 1. doi: 10.1002/ppul.25713.
    PubMed     Abstract available


  519. DEVI U, Pandita A
    Surfactant delivery via thin catheters: Methods, limitations, and outcomes.
    Pediatr Pulmonol. 2021;56:3126-3141.
    PubMed     Abstract available


  520. SALVATORE D, Carnovale V, Majo F, Padoan R, et al
    Disease characterization of people with cystic fibrosis and a minimal function mutation: Data from the Italian registry.
    Pediatr Pulmonol. 2021;56:3232-3241.
    PubMed     Abstract available


  521. SHARMA PB, Sathe M, Savant AP
    Year in Review 2020: Multisystemic impact of cystic fibrosis.
    Pediatr Pulmonol. 2021;56:3110-3119.
    PubMed     Abstract available


  522. SATHE M, Sharma PB, Savant AP
    Year in review 2020: Nutrition and gastrointestinal disease in cystic fibrosis.
    Pediatr Pulmonol. 2021;56:3120-3125.
    PubMed     Abstract available


  523. DACCO V, Rosazza C, Malfitano A, Sciarrabba CS, et al
    Cytokine storm syndrome in a young patient with cystic fibrosis.
    Pediatr Pulmonol. 2021;56:3435-3437.
    PubMed     Abstract available


  524. ARARAT E, Sonawalla A, Berlinski A, Tas E, et al
    Nutritional status between 5-10 years is associated with cystic fibrosis-related diabetes in adolescence.
    Pediatr Pulmonol. 2021;56:3217-3222.
    PubMed     Abstract available


  525. LANDMESSER KB, Autry EB, Gardner BM, Bosko KA, et al
    Comparison of the predictive value of area under the curve versus maximum serum concentration of intravenous tobramycin in cystic fibrosis patients treated for an acute pulmonary exacerbation.
    Pediatr Pulmonol. 2021;56:3209-3216.
    PubMed     Abstract available


  526. CAUDRI D, Turkovic L, Klerk NH, Rosenow T, et al
    A screening tool to identify risk for bronchiectasis progression in children with cystic fibrosis.
    Pediatr Pulmonol. 2021 Oct 1. doi: 10.1002/ppul.25712.
    PubMed     Abstract available


    September 2021
  527. OZDEMIR R, Gokce IK, Tekin S, Taslidere AC, et al
    The Protective Effects of Apocynin in Hyperoxic Lung Injury in Neonatal Rats.
    Pediatr Pulmonol. 2021 Sep 28. doi: 10.1002/ppul.25707.
    PubMed     Abstract available


  528. BUECHEL F, Usemann J, Aline A, Salfeld P, et al
    Feasibility of nasal NO screening in healthy newborns.
    Pediatr Pulmonol. 2021 Sep 27. doi: 10.1002/ppul.25702.
    PubMed     Abstract available


  529. HATZIAGOROU E, Toulia I, Avramidou V, Kampouras A, et al
    Change in CF care during COVID-19 pandemic: Single-center experience in a middle-income setting.
    Pediatr Pulmonol. 2021;56:3065-3067.
    PubMed     Abstract available


  530. NAYIR BUYUKSAHIN H, Emiralioglu N, Ademhan Tural D, Ozsezen B, et al
    Impact of COVID-19 on pediatric pulmonology healthcare practice.
    Pediatr Pulmonol. 2021;56:2811-2817.
    PubMed     Abstract available


  531. COLLACO N, Legg J, Day M, Culliford D, et al
    COVID-19: Impact, experiences, and support needs of children and young adults with cystic fibrosis and parents.
    Pediatr Pulmonol. 2021;56:2845-2853.
    PubMed     Abstract available


  532. MUIRHEAD CA, Palmrose W, Condren M, Rotolo SM, et al
    A clinician survey of use assessment, documentation, and education about cannabis in persons with cystic fibrosis.
    Pediatr Pulmonol. 2021;56:2879-2887.
    PubMed     Abstract available


  533. PORTERFIELD HS, Maakestad LJ, LaMarche MM, Thurman AL, et al
    MRSA strains with distinct accessory genes predominate at different ages in cystic fibrosis.
    Pediatr Pulmonol. 2021;56:2868-2878.
    PubMed     Abstract available


  534. BELCHER R, Zobell JT
    Optimization of antibiotics for cystic fibrosis pulmonary exacerbations due to highly resistant nonlactose fermenting Gram negative bacilli: Meropenem-vaborbactam and cefiderocol.
    Pediatr Pulmonol. 2021;56:3059-3061.
    PubMed     Abstract available


  535. BURRUS TE, Vogt H, Pettit RS
    Impact of a pharmacy technician and pharmacist on time to inhaled tobramycin therapy in a pediatric cystic fibrosis clinic.
    Pediatr Pulmonol. 2021;56:2861-2867.
    PubMed     Abstract available


  536. THORAT T, McGarry LJ, Bonafede MM, Limone BL, et al
    Healthcare resource utilization and costs among children with cystic fibrosis in the United States.
    Pediatr Pulmonol. 2021;56:2833-2844.
    PubMed     Abstract available


    August 2021
  537. MCGLYNN JR, Aoyama BC, Collaco JM, McGrath-Morrow SA, et al
    Family history of asthma influences outpatient respiratory outcomes in children with BPD.
    Pediatr Pulmonol. 2021 Aug 8. doi: 10.1002/ppul.25603.
    PubMed     Abstract available


  538. OTA C, Saito R, Tominaga J, Iwasawa S, et al
    Bilateral lung transplantation in a 9-year-old girl with bronchopulmonary dysplasia with pulmonary hypertension.
    Pediatr Pulmonol. 2021 Aug 5. doi: 10.1002/ppul.25597.
    PubMed     Abstract available


  539. YANG K, He S, Dong W
    Gut microbiota and bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2021;56:2460-2470.
    PubMed     Abstract available


  540. GOMES A, Patusco R, Chung M, Dreker MR, et al
    The associations between pediatric weight status and cystic fibrosis-related diabetes status and health-related quality of life among children and young adults with cystic fibrosis: A systematic review.
    Pediatr Pulmonol. 2021;56:2413-2425.
    PubMed     Abstract available


    July 2021
  541. MALLOY KW, Austin ED
    Pulmonary Hypertension in the child with Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2021 Jul 29. doi: 10.1002/ppul.25602.
    PubMed     Abstract available


  542. EPPS QJ, Epps KL, Young DC, Zobell JT, et al
    State of the art in cystic fibrosis pharmacology optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: III. Executive summary.
    Pediatr Pulmonol. 2021;56:1825-1837.
    PubMed     Abstract available


  543. GIFFORD AH, Sanville JL, Sathe M, Heltshe SL, et al
    Use of proton pump inhibitors is associated with lower hemoglobin levels in people with cystic fibrosis.
    Pediatr Pulmonol. 2021;56:2048-2056.
    PubMed     Abstract available


  544. POLLAK M, Shaw M, Wilson D, Solomon M, et al
    Bronchodilator responsiveness in cystic fibrosis children treated for pulmonary exacerbations.
    Pediatr Pulmonol. 2021;56:2036-2042.
    PubMed     Abstract available


  545. TREGGIARI D, Tridello G, Menin L, Borruso A, et al
    Role of sweat ion ratios in diagnosing cystic fibrosis.
    Pediatr Pulmonol. 2021;56:2023-2028.
    PubMed     Abstract available


  546. COLLINS R, Singh B, Payne DN, Bharat C, et al
    Effect of transfer from a pediatric to adult cystic fibrosis center on clinical status and hospital attendance.
    Pediatr Pulmonol. 2021;56:2029-2035.
    PubMed     Abstract available


  547. BOURGEOIS G, Magne F, Nove Josserand R, Durupt S, et al
    A formalized transition program for cystic fibrosis: A 10-year retrospective analysis of 97 patients in Lyon.
    Pediatr Pulmonol. 2021;56:2000-2006.
    PubMed     Abstract available


  548. ATLAS G, Yap M, Lim A, Vidmar S, et al
    The clinical features that contribute to poor bone health in young Australians living with cystic fibrosis: A recommendation for BMD screening.
    Pediatr Pulmonol. 2021;56:2014-2022.
    PubMed     Abstract available


  549. COHEN-CYMBERKNOH M, Ben Meir E, Gartner S, Reiter J, et al
    How abnormal is the normal? Clinical characteristics of CF patients with normal FEV1.
    Pediatr Pulmonol. 2021;56:2007-2013.
    PubMed     Abstract available


  550. HENTE E, Weiland J, Mullen L, Hawke J, et al
    Assessment of treatment burden and complexity in cystic fibrosis: A quality improvement project.
    Pediatr Pulmonol. 2021;56:1992-1999.
    PubMed     Abstract available


    June 2021
  551. BRUNO G, Donnarumma B, Inverardi A, Buonpensiero P, et al
    Long-term benefits of nusinersen in a child affected by cystic fibrosis and spinal muscular atrophy type 1.
    Pediatr Pulmonol. 2021;56:1806-1808.
    PubMed    


  552. BUSTAMANTE AE, Fernandez LT, Rivas LC, Mercado-Longoria R, et al
    Disparities in cystic fibrosis survival in Mexico: Impact of socioeconomic status.
    Pediatr Pulmonol. 2021;56:1566-1572.
    PubMed     Abstract available


  553. PLESKOVA J, Koucky V, Medunova K, Vlckova B, et al
    Reflex zone stimulation reduces ventilation inhomogeneity in cystic fibrosis: A randomised controlled cross-over study.
    Pediatr Pulmonol. 2021;56:1558-1565.
    PubMed     Abstract available


  554. LEITE LR, Queiroz KCV, da Silva FH, Coelho CC, et al
    Clinical use of the modified shuttle test in children with cystic fibrosis: Is one test sufficient?
    Pediatr Pulmonol. 2021;56:1550-1557.
    PubMed     Abstract available


  555. HERNANDEZ AM, Burdick B, Adeyemi-Fowode O
    Reproductive health counseling and contraceptive use in adolescents with cystic fibrosis.
    Pediatr Pulmonol. 2021;56:1543-1549.
    PubMed     Abstract available


  556. YILMAZ YEGIT C, Ergenekon AP, Mursaloglu HH, Cenk M, et al
    The effects of nebulizer hygiene training on the practices of cystic fibrosis patients and caregivers.
    Pediatr Pulmonol. 2021;56:1527-1533.
    PubMed     Abstract available


  557. EPPS QJ, Epps KL, Zobell JT
    Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. Cephalosporins and penicillins latest update.
    Pediatr Pulmonol. 2021;56:1784-1788.
    PubMed    


  558. MURSALOGLU HH, Yilmaz Yegit C, Ergenekon AP, Gokdemir Y, et al
    Screening of depression and anxiety in adolescents with cystic fibrosis and caregivers in Turkey by PHQ-9 and GAD-7 questionnaires.
    Pediatr Pulmonol. 2021;56:1514-1520.
    PubMed     Abstract available


  559. ASLANHAN U, Cakir E, Pur Ozyigit L, Kucuksezer UC, et al
    Pseudomonas aeruginosa colonization in cystic fibrosis: Impact on neutrophil functions and cytokine secretion capacity.
    Pediatr Pulmonol. 2021;56:1504-1513.
    PubMed     Abstract available


  560. LAFONT M, Morin C, Arrouy A, Rabeau A, et al
    Pediatrician intervention impacts parental smoking in cystic fibrosis, diabetes, and bronchiolitis.
    Pediatr Pulmonol. 2021;56:1716-1723.
    PubMed     Abstract available


  561. MCGARRY ME, McColley SA
    Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotype.
    Pediatr Pulmonol. 2021;56:1496-1503.
    PubMed     Abstract available


  562. ZOBELL JT, Moss J, Heuser S, Roe L, et al
    Understanding the expanding role of pharmacy services in outpatient cystic fibrosis care.
    Pediatr Pulmonol. 2021;56:1378-1385.
    PubMed     Abstract available


    May 2021
  563. PATEL M, McCracken C, Daley T, Stecenko A, et al
    Trajectories of oral glucose tolerance testing in cystic fibrosis.
    Pediatr Pulmonol. 2021;56:901-909.
    PubMed     Abstract available


  564. PERKINS RC, Shah M, Sawicki GS
    An evaluation of healthcare utilization and clinical charges in children and adults with cystic fibrosis.
    Pediatr Pulmonol. 2021;56:928-938.
    PubMed     Abstract available


  565. KONSTAN MW, Pasta DJ, VanDevanter DR, Wagener JS, et al
    Epidemiologic Study of Cystic Fibrosis: 25 years of observational research.
    Pediatr Pulmonol. 2021;56:823-836.
    PubMed     Abstract available


  566. EMIRZA C, Aslan GK, Kilinc AA, Cokugras H, et al
    Effect of expiratory muscle training on peak cough flow in children and adolescents with cystic fibrosis: A randomized controlled trial.
    Pediatr Pulmonol. 2021;56:939-947.
    PubMed     Abstract available


  567. EKINCI IB, Hizal M, Emiralioglu N, Ozcelik U, et al
    Differentially expressed genes associated with disease severity in siblings with cystic fibrosis.
    Pediatr Pulmonol. 2021;56:910-920.
    PubMed     Abstract available


  568. WILLIAMS WA 2ND, Jain M, Laguna TA, McColley SA, et al
    Preferences for disclosing adverse childhood experiences for children and adults with cystic fibrosis.
    Pediatr Pulmonol. 2021;56:921-927.
    PubMed     Abstract available


  569. PEREZ-TARAZONA S, Rueda Esteban S, Garcia-Garcia ML, Arroyas Sanchez M, et al
    Respiratory outcomes of "new" bronchopulmonary dysplasia in adolescents: A multicenter study.
    Pediatr Pulmonol. 2021;56:1205-1214.
    PubMed     Abstract available


  570. MUIRHEAD CA, Lanocha N, Markwardt S, MacDonald KD, et al
    Evaluation of rescue oral glucocorticoid therapy during inpatient cystic fibrosis exacerbations.
    Pediatr Pulmonol. 2021;56:891-900.
    PubMed     Abstract available


  571. OATES G, Rutland S, Juarez L, Friedman A, et al
    The association of area deprivation and state child health with respiratory outcomes of pediatric patients with cystic fibrosis in the United States.
    Pediatr Pulmonol. 2021;56:883-890.
    PubMed     Abstract available


  572. BEDI PK, DeHaan K, MacLean JE, Castro-Codesal ML, et al
    Predictors of longitudinal outcomes for children using long-term noninvasive ventilation.
    Pediatr Pulmonol. 2021;56:1173-1181.
    PubMed     Abstract available


    January 2021
  573. DU BERRY C, Westrupp N, Shanthikumar S, Welsh L, et al
    Associations between peak oxygen uptake, lung function and bronchiectasis in children with cystic fibrosis in the era of CFTR modulators.
    Pediatr Pulmonol. 2021 Jan 17. doi: 10.1002/ppul.25275.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neonatology is free of charge.